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Sammendrag på norsk / Summary in Norwegian 
 
Norsk tittel: Fysisk arbeidskapasitet og helse; Trening som behandling for 
pasienter med schizofreni 
 
Pasienter med schizofreni dør tidlig på grunn av hjertekarsykdom (HK) og har 
redusert gangfunksjon. Redusert fysisk arbeidskapasitet er nært knyttet til risiko for 
HK og til gangfunksjon målt som mekanisk nytteeffekt men har vært mangelfullt 
beskrevet for schizofreni gruppen. Få har undersøkt om trening kan normalisere fysisk 
arbeidskapasitet hos pasienter med schizofreni. 
I denne PhD avhandlingen har vi; I) sammenlignet utholdenhet (peak 
oksygenopptak) hos pasienter med schizofreni med normalverdier fra befolkningen, 
og evaluert sammenheng mellom utholdenhet, risikofaktorer for HK og livskvalitet, 
II) undersøkt effekten av effektiv utholdenhetstrening på mekanisk nytteeffekt for 
gange, risikofaktorer for HK, psykiatriske symptomer og livskvalitet, III) 
sammenlignet effekter av maksimal styrketrening og konvensjonell styrketrening hos 
friske, og IV) undersøkt effekten av maksimal styrketrening på maksimal styrke, 
mekanisk nytteeffekt for gange, psykiatriske symptomer og livskvalitet hos pasienter 
med schizofreni. 
I artikkel I, fant vi at utholdenheten til menn med schizofreni er 74 % av det 
normale. Forskjellen tilsvarer nærmere 30 år med aldring. For kvinner er 
utholdenheten 89 % av det normale, men ikke signifikant redusert. Kontrollert for 
alder, kjønn og røyking er det er 28 ganger mer sannsynlig at pasienter har en eller 
flere risikofaktorer for HK, hvis utholdenheten er redusert. Opplevelsen av god fysisk 
funksjon, generell helse, vitalitet og sosial funksjon øker med økende utholdenhet i 
pasientgruppen. 33 pasienter deltok i studien. 
I artikkel II, fant vi at 8 uker med intensiv aerob intervalltrening økte 
utholdenheten med 12 % og mekanisk nytteeffekt for gange med 12 % sammenlignet 
med ingen effekt i kontrollgruppen som spilte dataspill (Tetris). Ingen av gruppene 
endret psykiatriske symptomer eller risikofaktorer for HK.  
I artikkel III, fant vi at maksimal styrketrening gir større endring i maksimal 
styrke, eksplosiv styrke og arbeidsøkonomi sammenlignet med konvensjonell 
styrketrening som ofte benyttes av begynnere og i trening av pasienter. 
I artikkel IV, fant vi at 8 uker med maksimal styrketrening økte maksimal 
styrke med 38 % og mekanisk nytteeffekt med 20 % hos pasienter med schizofreni 
sammenlignet med ingen effekt i kontrollgruppen som trente på å spille Tetris. 
Konklusjonen på avhandlingen er at pasienter med schizofreni har redusert 
fysisk arbeidskapasitet og at det trolig bidrar til økt risiko for HK og redusert 
livskvalitet. Intensiv aerob intervalltrening og maksimal styrketrening øker 
utholdenhet, styrke og gangfunksjon og bør bli en del av standard behandling.  
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Summary 
Schizophrenia is a severe, chronic and debilitating mental illness. Patients often suffer 
a high risk of cardiovascular disease (CVD) and neurological abnormalities such as 
walking deficits. These physical symptoms reduce quality of life (QOL), the ability to 
carry out day-to-day activities and adherence to treatment. They are also closely 
related to inactivity and poor physical fitness, but just a few studies have explored 
these relationships in patients with schizophrenia.  
The aims of this thesis were:  
 
1. To evaluate peak oxygen uptake (VO2peak) in patients with schizophrenia 
(F20 to 29, ICD-10) compared to healthy individuals.  
2. To evaluate the relationships between VO2peak and the risk factors of CVD 
and QOL in patients with schizophrenia. 
3. To compare maximal strength training (MST) with conventional strength 
training (CON) based on the effects on maximal strength, explosive 
strength and work economy (i.e. net mechanical efficiency of walking 
[İnet]).  
4. To investigate the effects of high aerobic intensity interval training (HIT) 
and MST on VO2peak, maximal strength, İnet, the risk factors of CVD, 
psychiatric symptoms and QOL in patients with schizophrenia. 
 
In paper I, 33 patients were included to evaluate baseline fitness 
characteristics. Patients’ VO2peak were compared with normative VO2peak in healthy 
individuals from the Nord-Trøndelag Health Study (HUNT). VO2peak was 37.1 ± 9.2 
ml·kg-1·min-1 in men with schizophrenia; 74 ± 19 % of normative levels in healthy 
men (p < 0.001). VO2peak was 35.6 ± 10.7 ml·kg-1·min-1 in women with schizophrenia; 
89 ± 25 % of normative levels in healthy women (n.s.). Based on the odds ratio, 
patients were 28.3 (95 % CI=1.6-505.6) times more likely to have 1 CVD risk 
factors if they were below the VO2peak thresholds (44.2 and 35.1 ml·kg-1·min-1 in men 
and women, respectively). VO2peak correlated with The SF-36® Health Survey (SF-36) 
physical functioning (r = 0.58), general health (r = 0.53), vitality (r = 0.47), social 
function (r = 0.41) and physical component (r = 0.51) scores. 
 
 
x
In paper II, 25 patients were allocated to groups either completing HIT or 
playing computer games (CG) on three days per week for eight weeks. HIT consisted 
of 4 x 4 minutes intervals at 85 to 95 % of peak heart rate (HRpeak). The HIT group 
improved VO2peak by 12 % from 3.17 ± 0.59 L·min-1 to 3.56 ± 0.68 L·min-1 (p < 
0.001), more than the CG group (p = 0.014). İnet of walking improved by 12 % in the 
HIT group from 19.8 ± 3.0 % to 22.2 ± 4.5 % (p = 0.005), more than the CG group (p 
= 0.031). The psychiatric symptoms, expressed as Positive and Negative Syndrome 
Scale (PANSS) and Calgary Depression Scale for Schizophrenia (CDSS), did not 
improve in either group. 
In paper III, we compared MST with equal training volume (kg × sets × 
repetitions) of CON primarily with regard to work economy, and secondly one 
repetition maximum (1RM) and rate of force development (RFD) of single leg knee-
extension. In an intraindividual design, one leg was randomised to knee-extension 
MST (4 or 5RM) and the other leg CON (3 × 10 RM) three times per week for 8 
weeks. The gross work economy was improved with -0.10 ± 0.08 L·min-1 more after 
MST compared to CON (p = 0.011, between legs). From pre- to post-test the MST 
and CON improved net work economy with 31 % (p < 0.001) and 18 % (p = 0.01), 
respectively. MST also improved 1RM (p = 0.002) and dynamic RFD (p = 0.044) 
more than CON did. 
In paper IV, we investigated whether MST improved İnet in patients with 
schizophrenia. Patients were assigned to one of two groups: 1) MST consisting of 4 x 
4RM performed in a leg press apparatus or 2) playing computer games (CG). The 
baseline İnet was 17.3 % ± 1.2 % and 19.4 % ± 3.0 % in the MST (n=6) and CG 
groups (n=7), respectively, both of which can be is categorised as mechanical 
inefficiency. The MST group improved 1RM by 79 kg  (p = 0.006) and İnet by 3.4 %  
(p = 0.046) more than the CG group. The MST group improved 1RM and İnet, by 
means of 83 kg (i.e. 38 % change) (p = 0.028) and 3.4 % (i.e. 20 % change) (p = 
0.028), respectively. No change was observed in PANSS and the SF-36 (p > 0.05). 
In general, we concluded that men with schizophrenia have lower VO2peak 
levels than the general population. Patients with the lowest VO2peak have higher odds 
of having 1 risk factors for CVD. VO2peak correlates with particular aspects of 
perceived QOL. VO2peak and İnet improve significantly after 8 weeks of HIT. MST is 
more effective than CON for improving work economy, 1RM and RFD in untrained 
and moderately trained men. MST improves 1RM and İnet in patients with 
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schizophrenia. Neither HIT nor MST appears to influence symptoms of schizophrenia 
and QOL. 
HIT and MST could be used as therapeutic interventions for patients with 
schizophrenia to improve physical capacity, contribute to reducing the risk of CVD 
and to normalise a reduced İnet. 
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“For the first time in my life, I’m completing  
a task lasting as long as eight weeks” 
 
Patient’s statement 

1. Background 
 
1. Background 
 
Schizophrenia 
Schizophrenia is a severe, chronic and debilitating mental illness. Main characteristics 
include personality disorganisation, distortion of reality and dysfunction in social 
activities, domestic chores and occupational performance (World Health Organization 
2010). Patients suffering from schizophrenia often experience symptoms as “thought 
echo, thought insertion or withdrawal, thought broadcasting, delusional perception 
and delusion of control, influence or passivity, hallucinatory voices commenting or 
discussing the patient in third person, thought disorders and negative symptoms” 
(World Health Organization 2010). Symptoms like delusions and hallucinations and 
thought disorders are prominent in many patients with schizophrenia (World Health 
Organization 2010) and reflect an excess or distortion of normal function often 
referred to as positive symptoms. In contrast, negative symptoms reflect a 
weakening or loss of normal functions and represent symptoms such as affective 
flattening, apathy, social withdrawal, isolation, poor communication and cognitive 
impairments (Makinen et al. 2008; Faulkner 2005). Negative symptoms also appear as 
lack of motivation, initiative, drive and perseverance to carry out daily activities 
(Makinen et al. 2008).  
Lack of function in independent living, employment and social functioning are 
common in patients with schizophrenia (World Health Organization 2010). It is 
mainly problems carrying out activities of daily living that keep patients in hospital 
(Gunatilake et al. 2004). People with schizophrenia comprise about 10 % of the 
Norwegian recipients of disability benefit (McGlashan and Johannessen 1996).  
The course of illness may be either continuous or episodic with complete or 
incomplete remission (Hafner and an der Heiden 1999). The median lifetime 
prevalence is about 7 per 1000 (McGrath et al. 2008), and the first episode is at 
median age 22 and 24 years in men and women, respectively (Johannessen 2002). The 
specific causes of schizophrenia have not been determined, but both genetic and 
environmental factors seem to influence the development (Picchioni and Murray 
2007). Modern neuroimaging techniques have revealed abnormal brain structures and 
neurochemical composition in schizophrenia (van Os and Kapur 2009). Many 
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researchers believe that schizophrenia result from problems during neural 
development that leads to improper function of synaptic transition and plasticity (Yin 
et al. 2012). However, the relationship between biological alterations and actual 
experience are not fully understood (van Os and Kapur 2009). 
Pharmacological treatment, psychoeducation, family based therapy, cognitive 
therapy and other psychosocial interventions are recommended in the treatment 
guidelines (The Norwegian Directorate of Health 2012). Treatment may provide 
control over the symptoms, although it may not cure the illness (Gunatilake et al. 
2004). Maintenance treatment is regularly needed, but many patients still have 
residual symptoms, maladaptive behaviour and impaired social function (Gunatilake 
et al. 2004). In 2012, physical activity and training was included in “the national 
clinical guidelines for the management of psychotic disorders” (The Norwegian 
Directorate of Health 2012). Exercise training therapy may have distinct treatment 
benefits, but is not a stand-alone treatment option for schizophrenia (Faulkner 2005).  
 
Cardiovascular disease 
Schizophrenia and increased risk of cardiovascular disease (CVD). Patients 
suffering from schizophrenia have a mortality risk that is 2-3 times higher than the 
general population and a 12-15 years reduced life-expectancy (Saha et al. 2007). 
Schizophrenia causes a greater loss of lives than most other illnesses do (van Os and 
Kapur 2009). The leading cause of death is CVD (Brown et al. 2010; Osby et al. 
2000). Patients with schizophrenia are twice as likely to die of CVD as the general 
population (Brown et al. 2000; Hennekens et al. 2005) and they have higher rates of 
major risk factors for CVD (Birkenaes, Sogaard et al. 2006). The prevalence of 
metabolic syndrome is as high as 50 % in women and 35 % in men (Cohn et al. 2004; 
McEvoy et al. 2005). Other risk factors for CVD, that also constitute part of the 
metabolic syndrome, are also more frequent in populations with schizophrenia. High 
prevalence of hypertension, diabetes type 2, diminished glucose tolerance and insulin 
resistance have been reported (Dixon et al. 2000). Overweight and obesity are 
prevalent in both genders, but especially in women (Kurzthaler and Fleischhacker 
2001). This high risk of CVD could likely both be ascribed to genetics, unhealthy 
lifestyle (e.g., smoking, diet and inactivity), poor fitness, and adverse effects of 
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antipsychotic medication (Brown et al. 2000; Ryan and Thakore 2002; Strassnig et al. 
2011).  
Antipsychotic medication is currently an indispensable treatment option in 
most patients with schizophrenia. However, antipsychotic medication may result in 
hypertriglyceridemia, insuline recistence and/or weight gain with reduced treatment 
adherence and increased risk of CVD as consequence (McIntyre et al. 2001; Stahl et 
al. 2009). Therefore, prioritising modifiable risk factors such as increasing physical 
activity and fitness may have particular importance in patients with schizophrenia. 
The majority of patients with schizophrenia have a potential to improve CVD risk 
profile. 
 
Lifestyles that increase risk of CVD in patients with schizophrenia. Individuals 
with schizophrenia are vulnerable to adopt harmful lifestyles. Poor diets, high rates of 
smoking, drug abuse and a sedentary lifestyle are commonly observed (McCreadie 
2003). Their diets are high in fat and sugar and low in fibre (Brown et al. 1999; Ratliff 
et al. 2012). They are less likely than the general population to reach acceptable levels 
for consumption of fruit, vegetables, milk and potatoes (McCreadie 2003). Moreover, 
individuals with schizophrenia eat more full-fat cream, sweet drinks and 
hydrogenated fats than healthy controls (Amani 2007). Many people with 
schizophrenia are also heavy smokers. A study from Scotland found that 58 % of the 
patients were smokers compared to 28 % in the general population (Kelly and 
McCreadie 1999). Sixty-eight percent of the smokers had more than 25 cigarettes per 
day. The smokers were younger than non-smokers, more often men, had more 
hospitalisations and more contact with psychiatric services (Kelly and McCreadie 
1999). Patients with schizophrenia are also more likely to be inactive and less 
involved in sport activities (Vancampfort et al. 2011; Daumit et al. 2005). A low 
physical activity were almost three and a half times more prevalent in patients with 
schizophrenia compared to matched healthy controls (Vancampfort et al. 2012). Both 
the total amount of physical activity and the intensity are significantly lower than in 
controls (Vancampfort et al. 2012; Ratliff et al. 2012). Walking is the prominent 
physical activity and activities such as jogging, running, biking, gardening and yard 
work are less common (Daumit et al. 2005).  
An important observation is at that more patients than controls are overweight 
even if both groups have a similar physical activity level (McLeod et al. 2009). 
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McLeod et al. (2009) suggested the physical activity recommendations for people 
with schizophrenia should exceed those that apply for the general population to 
counteract the weight gain.  
 
Gait deficit 
A wide range of motor symptoms are consistently reported in patients with 
schizophrenia (Walther and Strik 2012). Gait deficits are part of these motor 
symptoms and are reflected by findings suggesting patients may walk slower than 
healthy controls due to shorter stride length (Putzhammer et al. 2004; Putzhammer et 
al. 2005b; Lallart et al. 2012). First-episode patients with schizophrenia walk with less 
arm swing but greater thorax lateral movements (sideways) compared to healthy 
controls (Stensdotter et al. 2012). The gait deficits seem to be independent of 
antipsychotic medication usage. However, gait deficits were less pronounced in young 
first-episode patients (Stensdotter et al. 2012) but more pronounced in patients treated 
with conventional antipsychotics (Putzhammer et al. 2004). The reduced stride length 
is particularly evident at a slow walking velocity and tends to normalise with 
increasing treadmill speed (Putzhammer et al. 2005b). Gait deficits are considered to 
be related to neurodevelopmental disturbances but the neurobiological cause is not 
agreed on (Walther and Strik 2012).  
Patients with gait deficits such as patients with Parkinson’s disease spend 
excessive metabolic energy during walking (i.e. reduced walking 
economy/mechanical efficiency of walking) (Christiansen et al. 2009). This 
overconsumption of energy reduces their endurance and their capacity to perform 
day-to-day activities. Surprisingly, the metabolic consequences of gait deficits in 
schizophrenia are unexplored. Gait deficits may influence the patients’ well-being, 
quality of life (QOL), and adherence to antipsychotic treatment (Putzhammer et al. 
2005a; Robinson et al. 2002). Thus, interventions to improve walking 
economy/mechanical efficiency of walking may be especially important in patients 
with schizophrenia. 
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QOL 
The World Health Organization (WHO) (1995) defines QOL as “individuals’ 
perception of their position in life in the context of the culture and value systems in 
which they live and in relation to their goals, expectations, standards and concerns”. 
QOL depends on “the person’s physical health, psychological state, level of 
independence, social relationship, personal beliefs and relationship to their 
environment” (World Health Organization 1995). 
Several aspects of schizophrenia illness may affect patients’ QOL. However, 
QOL is subjective and patients with schizophrenia may not report/or perceive low 
QOL contrary to ratings given by experienced staff (Linaker and Moe 2005).  
High levels of cardio respiratory fitness are associated with high levels of 
QOL in healthy young adults (Sloan et al. 2009). QOL was also found to improve in a 
dose dependent manner in sedentary women when they increased their physical 
activity level (Martin et al. 2009). The physical activity level of patients with 
schizophrenia is a significant predictor of health related QOL (Vancampfort et al. 
2011). Moreover, obesity and physical fitness may be perceived as a physical health 
problem, not mental (Strassnig et al. 2003). 
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Physical fitness and exercise training 
The term “physical fitness” embraces a broad range of physiological characteristics 
such as cardio-respiratory fitness, body composition, muscular strength, endurance, 
and flexibility (Lamonte and Blair 2012). These attributes relate to an individual’s 
ability to perform physical activity as well as being outcomes of physical activity 
(Lamonte and Blair 2012).  
“Physical activity” refers to behaviour and is defined as “any bodily 
movement produced by skeletal muscles that requires energy expenditure” (World 
Health Organization 2012). This comprehensive definition incorporates physical 
activities ranging from top-level athletics to everyday life activities.  
Physical activity generally refers to movements that enhances health (U.S. 
Department of Health and Human Services 2008) and even as little as 15 minutes per  
day may provide significant reductions in all-cause mortality, cancer mortality and 
CVD mortality (Wen et al. 2011). The relationship between physical activity and 
health is, however, more complex. Physical activity, fitness and health are interactions 
that mutually influence each other and separately they are influenced by both genetic 
and environmental factors (Bouchard et al. 2012). Some studies suggest that fitness 
level is a stronger predictor of all-cause mortality than actual physical activity level 
(Blair et al. 2001; Lee et al. 2011). The term “exercise training” is used to describe 
methods of the physical activity that are known to improve specific aspects of 
physical fitness. Thus, exercise training and physical fitness are more suitable terms 
that comply with the aim of medical treatments to improve specific health variables.  
This thesis focuses on the type and amount of physical activity, or exercise 
training that improves fitness to provide significant health benefits. 
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Physical fitness variables 
Physical fitness in terms of maximal strength and aerobic endurance has a significant 
relationship to health and longevity (Kodama et al. 2009; Ruiz et al. 2008). This 
section provides an overview of the main fitness variables resulting from maximal 
strength training and aerobic endurance training. 
Three factors explain the variance between individuals in aerobic endurance 
performance; maximal oxygen uptake (VO2max), lactate threshold (LT) and work 
economy (otherwise known as mechanical efficiency) (Pate and Kriska 1984). 
 
Maximal and peak oxygen uptake. Oxygen comprises 20.93 per cent of the air at 
sea level and plays a vital role in cell respiration and energy metabolism. During 
aerobic exercise, oxygen uptake closely mirrors energy consumption and each litre of 
oxygen consumed corresponds to approximately 5 kcal of energy. At rest the human 
body require 3.5 ml·kg-1·min-1 of oxygen to sustain its vital processes. During 
exercise, the pulmonary oxygen uptake increases to meet the increasing energy 
demand. The VO2max is defined as “the highest rate at which oxygen can be taken up 
and utilised by the body during severe exercise” (Bassett and Howley 2000). In 
healthy subjects, this may be observed as a plateau, where the oxygen uptake settles 
even though the workload is further increased. Maximal tests are often confirmed by a 
respiratory exchange ratio (RER, the ratio between the amount of carbon dioxide 
exhaled and oxygen inhaled in one breath) above 1.15 and a blood lactic acid level 
above 8-9 mmol. Patients may not manage to reach these criteria therefore the term 
peak oxygen uptake (VO2peak) is often used. VO2peak is also used to describe the 
highest oxygen uptake during maximal work with small muscle mass such as single 
leg knee-extension. Conversely, the VO2max is measured during work with large 
muscle groups, such as walking or running, by gradual and stepwise increasing 
workload until exhaustion. Elite male endurance athletes may reach a VO2max as high 
as >90 ml·kg-1·min-1. Normative VO2peak for 30-39 year olds are 39.8 ml·kg-1·min-1 
and 48.8 ml·kg-1·min-1 in women and men, respectively (Aspenes et al. 2011). VO2peak 
are often presented as ml·kg-0.75·min-1 (e.g. running) or ml·kg-0.67·min-1 (e.g. knee 
extension) to normalise inter-individual differences and intra-individual changes in 
bodyweight (Rogers et al. 1995; Helgerud 1994).  
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VO2max uptake sets the upper limit for performance in an aerobic endurance 
event (Bassett and Howley 2000; Kodama et al. 2009). Reduced VO2max or VO2peak is 
also a strong predictor of CVD and all-cause mortality (Blair et al. 1996; Kodama et 
al. 2009). 
   
Lactate threshold. Lactate (La-) is a product of anaerobic carbohydrate metabolism. 
La- is formed from glucose breakdown when the oxygen supply is not sufficient to 
allow complete oxidation. La- is not a waste product but an important source of 
energy. During rest and moderate exercise, the removal of La- exceeds the production 
and blood La- is always balanced at a sustainable level. Some of the blood La- is 
consumed as fuel by the heart and working oxidative muscle fibres and some is used 
for gluconeogenesis by the liver. The rate of La- removal depends on the metabolic 
rate of resting and exercising muscles. However, during short-term intense exercise, 
the La- level may increase to an unsustainable level and prevents intermediary 
metabolism being accomplished. Further exercise intensity must thereafter be reduced 
to allow La- removal. The LT is the threshold for lactate built-up, commonly 
described as “the highest working intensity at which the lactate production equals its 
elimination”  (Helgerud 1994). The LT may differ between individuals in terms of 
oxygen uptake, but not when expressed as a percentage of VO2max (Helgerud 1994). 
 
Work economy. Work economy is the oxygen uptake required to maintain a constant 
power output or velocity of movement (McArdle et al. 2010, p. 207). Walking or 
running economy is typically measured during steady rate treadmill walking or 
running at a standard inclination and speed. Work economy may also be measured at 
a set watt load during cycling or during work with small muscle mass such as single 
leg knee-extension, plantar flexion or arm curl exercise (Wang et al. 2008; Kemi et al. 
2011; Heggelund et al. 2013). Lower oxygen cost at a standardised workload means 
better economy. 
 
Mechanical efficiency. Mechanical efficiency denotes the ratio between energy 
expenditure (energy input) of exercise and the fraction of energy expenditure that 
appear as external work (energy output) (McArdle et al. 2010, p. 207). The net 
mechanical efficiency (İnet) of walking differs from mechanical efficiency of walking 
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in that the energy input term is the net rate of metabolic energy expenditure (i.e. leave 
out resting metabolic rate and the horizontal component walking). Contrary to 
walking economy, İnet is measured at a given watt load, thus taking into account the 
bodyweight of each individual. The concept of İnet also considers the relationship 
between energy input and output unlike work economy, which only measures the 
energy input (viz. pulmonary oxygen uptake). İnet in healthy individuals is typically 
about 25 % (Hoydal et al. 2007) and may reach 30 % at best (Perrault 2006). A lower 
percentage means poorer efficiency. 
Work economy or İnet becomes progressively more important as the duration 
of the endurance exercise increases as success depends on the ability to perform work 
with the lowest possible oxygen uptake (McArdle et al. 2010, p. 207). For many 
patients, a poor walking economy/İnet in addition to a low VO2peak could be a limiting 
factor for performance of daily physical activities including domestic chores, work 
and leisure time physical activity.  
 
Maximal strength. Strength is defined as the maximal force (in Newton) or torque 
(in Newton metre) a muscle or muscle group can generate at a specified or determined 
velocity (Komi 2003, p. xiv). Strength is specific to the given action and the velocity 
of its performance. Maximal strength are typically measured as one repetition 
maximum (1RM) which denotes the heaviest weight that can be lifted in 1 repetition 
in a specific dynamic exercise (e.g., bench press, leg press, squat or knee-extension). 
Strength may also be measured as the maximal force in an isometric muscle action. 
 
Power and rate of force development (RFD). Work is performed as force is applied 
to an object and displacement occurs. Power is the rate of performing work, that is the 
product of force and velocity (Komi 2003, p. xiii). RFD is typically calculated from a 
force-time curve, as the force difference between 10 % to 90 % of the peak force 
divided by the elapsed time interval (Weiss 2000). This ratio is often termed explosive 
strength (Zatsiorsky 2003).  
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Exercise training 
The objective of exercise training is to stimulate structural and functional adaptations 
that improve performance in a specific task (McArdle et al. 2010, p. 452). These 
adaptations are achieved by adhering to carefully planned training programs with 
attention to principles such as specificity and overload in frequency, intensity and 
duration (McArdle et al. 2010, p. 452). The same principles are applicable for both 
athletes and untrained individuals. 
 
Aerobic endurance training. Aerobic endurance training aims to improve endurance 
performance through improving VO2peak, LT and work economy (or İnet) (Bassett and 
Howley 2000). Trainings sessions are often specific and target one of those variables. 
The LT tends to improve in absolute terms with training that improves VO2max 
(Londeree 1997), but the LT does not appear to change when reported as a percentage 
of VO2peak (Helgerud 1994; Helgerud et al. 2007). Thus, aerobic endurance training 
programs are frequently focused on improve VO2peak and work economy (Helgerud et 
al. 2007).   
Having a high VO2peak is dependent on having a well-developed system for 
transportation of oxygen from the environment to the mitochondria. The oxygen 
transport pathway includes the lungs, the heart and vasculature, the blood and the 
muscles (Wagner 2005). This system of oxygen transport and utilisation is a highly 
integrated system through the body (Wagner 2008). Aerobic endurance training 
enhances every part of this system except the lungs (Wagner 2005). The cardiac 
output and the heart’s stroke volume are particularly important (Wagner 2000). There 
is now considerable experimental support suggesting that training oxygen transport 
and utilisation to improve VO2peak is most successfully carried out training at a high 
oxygen uptake. Several studies have compared different training intensities ranging 
from long slow distance training (at 70 % peak heart rate) to high aerobic intensity 
training (intervals at 85-95 % peak heart rate). Their overall conclusion is that the 
critical stimulus is the total amount of time spent at 85-95 % peak heart rate 
(Helgerud et al. 2007; Rognmo et al. 2004; Wisloff et al. 2007). Although several 
strategies may be utilised to achieve this goal, the high aerobic intensity training 
(HIT) performed as 4 times 4 minutes intervals are a close to optimal combination of 
intensities, length of intervals and rest periods to improve VO2peak (Helgerud et al. 
 
 10
1. Background 
 
2007; Rognmo et al. 2004; Wisloff et al. 2007). HIT also significantly improves work 
economy (Helgerud et al. 2007).  
 
Strength training. Increased maximal strength and RFD occur because of 
adaptations in the skeletal muscles morphology, architecture and nervous system 
(Folland and Williams 2007; Aagaard 2003). The most pronounced morphological 
changes are increased cross-sectional area of whole muscle and individual muscle 
fibres due to hypertrophy (Folland and Williams 2007). However, a large proportion 
of strength and RFD improvements may be explained by improved neural function. 
The neural changes include increased motor unit firing rates, increased motoneuron 
excitability, decreased neural inhibition and increased central descending motor drive 
(Aagaard 2003). Training programs aimed to maximise neural adaptations (e.g. 
maximal strength training [MST]) may improve maximal strength and RFD with no 
or minor changes in muscle mass (Aagaard 2003). 
Resistance exercise can be performed in various ways by manipulating 
variables such as loading, repetition velocity, rest periods and volume (kg × sets × 
repetitions) (Bird et al. 2005). Based on unequal neural, morphological, metabolic, 
strength and power adaptations to these acute program variables, different training 
methods have been developed (Bird et al. 2005; Campos et al. 2002). MST aim to 
improve maximal strength and RFD (Hoff and Almåsbakk 1995) while training 
programs applied by body builders primarily aim to increase muscle fibre hypertrophy 
and secondly strength (Bird et al. 2005). Although these training methods overlap in 
their subsequent adaptations, the principle of specificity (Sale and MacDougall 1981) 
suggest that it is possible to manipulate variables to achieve greater adaptations in 
selected outcomes. To improve maximal strength and RFD, training programs 
utilising heavy loads (>85 % of 1RM), few repetitions (5), maximal mobilisation of 
force in the concentric part of the movement and long resting periods (>3 minutes) are 
beneficial (Bird et al. 2005; Campos et al. 2002; Cormie et al. 2011; Hoff and 
Almåsbakk 1995). Conversely, training programs to induce muscular hypertrophy 
regularly involve a higher number of repetitions and sets using a moderate load (70-
75 % 1RM) as well as intentional slow repetition velocity (concentric and eccentric) 
and shorter rest periods (Bird et al. 2005; Schoenfeld 2010; Wernbom et al. 2007). 
Conventional resistance training programs (CON) employ moderate loads 
corresponding to 60-70 % of 1RM for a repetition range of 8-12 performed with slow 
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to moderate velocities (Ratamess et al. 2009). The conventional resistance training 
programs are considered safe for novice training and effective to improve strength and 
rapid force characteristics for untrained and moderately trained individuals (Ratamess 
et al. 2009). 
Strength training, and MST in particular, improves work economy (Hoff et al. 
1999) and İnet (Hoff et al. 2007). The exact mechanism behind this improvement are 
still somewhat blurred but the improved efficiency of the legs occurs in the skeletal 
muscle and reduces the muscle’s blood flow with no change in arterial-venous oxygen 
difference (a-vO2diff) (Barrett-O'Keefe et al. 2012). The exact program variables of a 
resistance-training program that improve work economy/efficiency are not 
determined. 
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Relationships between fitness and health in patients with 
schizophrenia 
 
VO2peak 
Cardiorespiratory fitness, measured as VO2peak is a strong predictor of CVD and all-
cause mortality (Blair et al. 1996; Kodama et al. 2009; Barlow et al. 2012). Higher 
VO2peak levels reduces the risk of CVD, coronary heart disease and all cause mortality 
(Kodama et al. 2009). VO2peak is often a stronger predictor of mortality than 
conventional risk factors for CVD (Myers et al. 2002). McAuley and Blair (2011) 
identified reduced VO2peak as a greater health threat than obesity and suggested that 
more emphasis should be put on increasing VO2peak. This might be especially 
important considering that higher levels of VO2peak seem to offset the increased health 
risk associated with obesity (Lee et al. 2005). Findings from the epidemiological 
Nord-Trøndelag Health Study (the HUNT Study) demonstrate that physically active 
people with a clustering of cardiovascular risk factors appear to have a comparable 
risk of premature death as inactive individuals without risk factors (Tjonna et al. 
2010). In the same cohort, men with VO2peak below 44.2 ml·kg-1·min-1 were eight 
times more likely to have a cluster of CVD risk factors compared with men above 
50.5 ml·kg-1·min-1 (Aspenes et al. 2011).  
Low aerobic capacity is usually a result of inactivity and lack of overload on 
the cardiovascular system. Thus, aerobic capacity is a modifiable risk factor and 
prognosis likely improves through increasing VO2peak.  
 
1RM 
Muscular strength is a risk factor that is inversely associated with all-cause mortality, 
CVD mortality, suicide and the prevalence of metabolic syndrome (Jurca et al. 2004; 
Ruiz et al. 2008; Ortega et al. 2012). Several important health benefits have been 
identified, including increased muscle mass, increased resting metabolic rate, 
increased mobilisation of adipose tissue, enhanced insulin sensitivity, improved 
glucose tolerance and decreased diastolic blood pressure (Tresierras and Balady 
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2009). These adaptations are associated with reduced risk of CVD and prevalence of 
metabolic syndrome (Williams et al. 2007). 
 
İnet and walking economy 
Walking constitutes an important part of the ability to function in daily life. This 
ability may include daily activities such as domestic chores, walking to the shops, 
picking up the post and attending to medical services. Walking deficits in patients 
with schizophrenia are related to a reduced QOL (Putzhammer et al. 2005a), and a 
similar relationship may apply to reduced walking economy/İnet.  
Patients with chronic obstructive pulmonary disease and patients with 
coronary artery disease walk with mechanical inefficiency (Hoff et al. 2007; Hoydal 
et al. 2007). Walking economy/İnet has not yet been investigated in patients with 
schizophrenia, to the knowledge of the author.  
 
Mental health effects of exercise 
Several factors must be considered when exploring the effects of exercise on mental 
health in schizophrenia. Exercise could have an impact a number of aspects of the 
patients’ mental health, including symptoms of schizophrenia, depression and QOL. 
The effects could be either temporary or long-lasting. Moreover, there are different 
methods of exploring and measuring these symptoms, such as interview, observation 
of patients and questionnaires. There are also numerous individual or group based 
exercise interventions of different lengths, type and intensity that hold the potential of 
having distinct effects on mental health. Furthermore, several confounding variables 
from participating in exercise, such as the social interaction and distraction, might 
have significant benefits on mental health variables (Martinsen et al. 1989a; 
Martinsen et al. 1989b).   
Whether improved mental health results from physical activity alone or 
improved fitness has not received much attention. Reductions in depression scores 
and anxiety in clinical depression and anxiety disorders are found independently of 
improved VO2peak (Martinsen et al. 1989a; Martinsen et al. 1989b). However, results 
from the Aerobics Centre Longitudinal Study suggested that people with a low 
VO2peak are characterised by depressive symptoms and low emotional well being 
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(Galper et al. 2006). High levels of VO2peak are associated with high levels of QOL 
(Sloan et al. 2009). Body mass index (BMI) is inversely related to QOL in patients 
with schizophrenia (Strassnig et al. 2003) but the relationship between VO2peak and 
perceived QOL has not been evaluated systematically.  
Pajonk and colleagues (2010) found a greater hippocampus volume after three 
months endurance training in eight patients with schizophrenia. They also found that 
the hippocampus volume change correlated with the improved VO2peak. Another study 
disagreed with this finding, although they found increased VO2peak to be associated 
with an increase in total cerebral matter volume, an attenuated increase in lateral and 
third ventricle volume, and cortical thickening in the left hemisphere (Scheewe et al. 
2012c).  
It has been suggested that physical activity can alleviate some of the negative 
symptoms and can be used as a coping strategy to control positive symptoms in 
schizophrenia (Faulkner 2005). Patients may have less psychotic features on days of 
physical activity suggesting an acute effect (Chamove 1986). Regular training may 
lead to a reduction in overall psychopathology (Lukoff et al. 1986). Recently, a larger 
randomised trial found a significant improvement in symptoms of schizophrenia as 
well as depression and need of care (Scheewe et al. 2012a). The trial included mostly 
outpatients and the training period was 6 months. 
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Methodological considerations of experimental studies in 
schizophrenia 
Patients with schizophrenia tend to have problems with attending randomised 
controlled trials (Abbott et al. 2005; Beebe et al. 2005). In one study trying to recruit 
patients to a health promoting trial, 25 out of 36 eligible patients agreed to meet the 
researchers. The researchers then made 123 visits before 12 of those ultimately 
provided informed consent (Abbott et al. 2005). After randomisation, 9 patients 
declined to participate and they were left with 3. The authors suggested that 
randomised controlled trials have limitations for patients with schizophrenia. One of 
these limitations may be that only the less severely ill patients attend with a selection 
bias so that is harder to generalise the results to the wider population of schizophrenia 
patients (Correll et al. 2011).  
A randomised controlled trial is the most powerful experimental study design 
and the most strict method to determine whether a cause-effect relation exists between 
a treatment and an outcome (Stolberg et al. 2004). By definition, randomisation is the 
process of assigning patients to treatment and control groups, under the assumption 
that each patient has an equal probability of being assigned to any of the groups 
(Hulley 2001). The randomisation procedure ensures that characteristics are 
approximately equally distributed between the groups so that the groups do not differ 
in any systematic way in the confounding variables and the dependent variable. 
Therefore, any significant differences in outcome measures could be attributed to the 
intervention. Proper randomisation ensures no previous knowledge (intentional nor 
unintentional) of group assignment (Hulley 2001).  
Non-randomised controlled trials are experimental studies in which patients 
are allocated to interventions using methods that are not random (Deeks et al. 2003). 
The most clear difference between randomised and non-randomised trials is the 
potential for selection bias in terms of biased allocation of patients to a given 
intervention (Deeks et al. 2003). Selection bias is introduced when patients allocated 
to one intervention have different characteristics from those in the alternative 
intervention (Deeks et al. 2003). Non-randomised controlled trials are able to identify 
associations between an intervention and an outcome (Sibbald and Roland 1998). 
However, bias may exist and might be difficult to detect (Kadar 1997). 
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2. Aims and Hypotheses 
 
The overall aim of this thesis was to evaluate fitness, health and exercise training 
therapy in patients with schizophrenia. This aim was examined in four studies 
(paper I-IV) with distinct aims and hypotheses:  
 
Paper I 
x To evaluate VO2peak during walking or running in men and women with 
schizophrenia compared to VO2peak in healthy individuals from the Nord-
Trøndelag Health Study (HUNT).  
x To evaluate relationships between VO2peak, risk factors for CVD, and QOL. 
x We hypothesised that patients with schizophrenia had reduced VO2peak 
compared to normative healthy individuals.  
 
Paper II 
x To investigate the effects of HIT compared with physical inactivity in the form 
of playing computer games (CG), in patients suffering from schizophrenia. 
The outcome variables were VO2peak, İnet of walking, CVD risk factors and 
symptoms of schizophrenia.  
x We hypothesised that >80 % adherence to 24 training sessions with HIT 
during 8 weeks would improve the VO2peak and İnet more than the same 
amount of time spent on CG. 
 
Paper III 
x The aim of this study was to compare maximal strength training (MST) with 
conventional strength training (CON) based on effects on maximal strength, 
explosive strength and work economy (otherwise known as İnet) 
x Our hypotheses were that MST improves work economy, maximal strength 
and RFD more than CON does. 
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Paper IV 
x To evaluate the effects of 8 weeks MST on 1RM, work economy (viz. İnet of 
walking), symptoms of schizophrenia and QOL. We chose to compare the 
MST with CG.  
x We hypothesised that the MST would improve 1RM and work economy (viz. 
İnet of walking) more than the CG
18
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Subjects 
Paper I, II and IV. Paper I is based on data from 33 patients with ICD-10 
schizophrenia, schizotypal or delusional disorders (F20 to F29) (figure 1). Paper II 
and IV together (figure 1) are based on data from 32 patients at the University 
Hospital. All patients were treated with antipsychotic medication. Exclusion criteria 
were known coronary artery disease, known chronic obstructive pulmonary disease, 
and not being able to perform physical treadmill testing and exercise. A physician 
examined patients at inclusion to the study and reviewed medical records for potential 
exclusion criterions. The first patients were allocated to HIT, the next group to CG 
and the last patients to MST. The allocations to the groups were non-randomised but 
the patients were not able to choose group themselves. Neither patients nor staff 
achieved information that could influence their preference to a particular intervention. 
Testing was performed the week before and the week after the 8-week intervention 
(figure 2). 
 
Paper III. We included ten healthy, non-smoking men. They were moderately trained 
or untrained and did not participate in concurrent strength training during the study 
period.  
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Paper I  
Baseline results from patients (N=33) 
 
Paper II
 
Figure 1. Patients with schizophrenia included in studies (papers I, II and IV). Paper I used 
baseline results from 33 patients. 32 patients were allocated to three non-randomised groups (paper II 
and IV) (Heggelund et al. 2011a; Heggelund et al. 2012; Heggelund et al. 2011b). 
 Paper IV
High aerobic intensity 
training 
N= 16 
 Paper II and IV 
Maximal strength training Computer game 
N= 7 N= 9 
  
Lost to follow-up Lost to follow-up Lost to follow-up 
N= 4 N= 1 N= 2 
Analysed Analysed Analysed 
N= 12 N= 6 N= 7 
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Pre-test
(1 week)
Post-test
(1 week)
Intervention period 
(8 weeks)
High 
aerobic intensity 
training
Inclusion-
3 groups:
Maximal strength
training
Computer games
 
Figure 2. Designs presented in paper II and IV. Paper II (Heggelund et al. 2011b) present effects of 
high aerobic intensity training and paper IV (Heggelund et al. 2012) present effects of maximal 
strength training. The computer game group served as a control group in both papers II and IV. Pre- 
and post-test measurements were made the week before and after the 8 weeks intervention period. The 
groups were non-randomised. 
 
 
Experimental designs 
In paper I, we evaluated baseline VO2peak measures from 33 patients with 
schizophrenia and compared them with age and sex specific strata from the Nord-
Trøndelag Health Study (the HUNT Study). We also evaluated risk factors for CVD 
as well as QOL in patients above/below the mean VO2peak thresholds defined by 
Aspenes, Nilsen et al. (2011). The design resembles a cross-sectional study, but the 
sample size is low and patients were not randomly selected from the population. 
In papers II and IV we performed 8 week non-randomised controlled trials to 
evaluate the effects of HIT and MST in patients with schizophrenia. The control 
group spent an equivalent amount of time being physical inactive playing computer 
games. 
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Paper III is a randomised controlled trial. Using an intraindividual design, one 
leg was randomised to 8-weeks MST and the other to equal volume CON in a 
counterbalanced fashion. 
 
Measurements 
Oxygen uptake 
Peak exercise testing. We applied an individualised incremental protocol to measure 
VO2peak and peak heart rate (HRpeak). In papers I, II and IV we used the Cortex 
Metamax II portable ergospirometry system (Cortex Biophysik GmbH, Leipzig, 
Germany). In paper III we used a Cortex Metamax 3x. We measured HRpeak using a 
heart rate monitor (Polar Electro, Finland) and in study we also drew blood samples to 
measure lactate concentration ([La-]b) using a YSI Sport Lactate Analyzer (Yellow 
Springs Instruments Co, USA). The treadmill protocol has previously been described 
(Helgerud et al. 2007). The same principles of increasing workload to exhaustion 
were applied during single-leg knee extension in paper III. 
 
Sub-maximal exercise testing. Subjects performed continuous steady rate 
submaximal work through a period of 6 minutes (5 minutes in paper III). The 
respiratory measurements made through the first half of the last minute of the bout 
were used to evaluate the submaximal performance. In paper III, the workload was 20 
watt and determined by the Monark Ergomedic 839E electrical braked cycle 
ergometer (Monark Exercise AB, Varberg, Sweden). In papers I, II and IV the 
subjects walked at an individually adjusted speed and incline corresponding to 60 watt 
at pre- and post-test. In paper III, we present these measures in terms of work 
economy. In paper III and IV, we further calculated the energy input and output to 
determine the İnet of walking. The procedures are properly described in paper IV.   
 
Knee-extension. To perform testing in paper III we built the single leg knee-
extension apparatus according to a model described by (Andersen et al. 1985; 
Andersen and Saltin 1985; Richardson et al. 1995). Subjects were sitting in the Felax 
HG-5114 knee extension machine with the leg fastened to an aluminium-brace that 
was connected via a bar to the pedal arm of a Monark Ergomedic 839E electrical 
 
 22
3. Methods 
 
braked cycle ergometer (Monark Exercise AB, Varberg, Sweden) (figure 3). The 
knee-extension apparatus were adjusted to produce a 90° -170° arc of the lower leg. 
Subjects were not strapped to the seat. We instructed the subjects to hold their hands 
in their lap and to perform the exercise by using the knee-extensors only. Subjects 
were corrected if unwanted movements occurred. The bicycle ergometer was 
calibrated before each test and the friction made by the crank was subtracted in order 
to give a valid watt load. One week before pre-testing the subjects spent 20 min 
training with each leg to become familiarised with the test (Andersen et al. 1985; 
Richardson et al. 1995). 
 
 
 
Figure 3. The knee-extension apparatus. 
 
 
Normative VO2peak 
In paper I, we compared the patients’ VO2peak with age and sex specific strata from 
the Nord-Trøndelag Health Study (the HUNT Study) (Aspenes et al. 2011). The 
HUNT study is an epidemiological study of the general population in the 
neighbouring county to the university hospital. The HUNT Fitness study tested 
VO2peak in 4 631 healthy individuals (20 to 90 years old) using mixing chamber gas-
analyzer ergospirometry (Cortex MetaMax II, Cortex, Leipzig, Germany) and an 
individualised protocol that has close resemblance to the protocol used in the present 
study. 14.1 % of the participants reported to be inactive, defined as no activity or 
exercising less than once per week. For each patient with schizophrenia, we estimate
a normative VO
d 
trata 
 
e 
he 
2peak, namely the mean value defined in the HUNT Fitness study s
for the corresponding sex and age. We called the VO2peak estimated from sex and age
strata independent of physical activity level the HUNT general. The VO2peak from ag
and sex strata for healthy inactive men and women was called HUNT inactive. T
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patients’ VO2peak as a percent of HUNT general and HUNT inactive VO2peak was 
calculated as: (achieved VO2peak ÷ age predicted VO2peak) · 100.  
 
 
Table 1. Reference intervals for CVD risk factors.  
Risk factor Reference intervals 
Hypertension Diastolic pressure 90 mmHg and/or Systolic 
pressure 140 mmHg 
Elevated blood glucose >6.0 mmol·L-1 
Elevated total cholesterol >6.1 mmol·L-1 in patients <30 years old  
>6.9 mmol·L-1 in patients 30-49 years old  
>7.8 mmol·L-1 in patients 50 years old 
Elevated LDL-cholesterol >4.3 mmol·L-1 in patients <30 years old  
>4.7 mmol·L-1 in patients 30-49 years old  
>5.3 mmol·L-1 in patients 50 years old 
Reduced HDL-cholesterol <1.0 mmol·L-1 
Elevated triglyceride >2.6 mmol·L-1 
Obesity BMI 30.0 kg·m-1 
Taken from the “Nordic Reference Interval Project 2000” and the “2007 Guidelines for the 
management of Arterial Hypertension” (Mancia et al. 2007; Rustad et al. 2004). 
 
 
Conventional CVD risk factors 
In papers I and II, morning fasting blood levels were taken. Serum glucose was 
analysed using the Reflotron Plus system (Roche Diagnostics, Mannheim, Germany). 
HDL (high-density-lipoprotein) cholesterol, total cholesterol and triglyceride 
concentrations in serum were measured using a Modular P chemistry analyser (Roche 
Diagnostics, Mannheim, Germany). LDL cholesterol was calculated using the 
Friedewald, Levy et al. (1972) equation. BP (blood pressure) was measured using a 
Maxi-Stabil 3 (Welch Allyn, Jungingen, Germany). Patients were sitting and had 
rested for at least 5 minutes. In paper I, risk factors were classified according to 
reference intervals (Mancia et al. 2007; Rustad et al. 2004) presented in table 1.  
In the HUNT study men and women below 44.2 ml·kg-1·min-1 and 35.1 ml·kg-
1·min-1, respectively, were more likely to have CVD risk factors (Aspenes et al. 2011). 
These VO2peak values were used as threshold values. Thus, we evaluated the 
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occurrence of conventional CVD risk factors in patients below versus patients above 
these VO2peak thresholds (paper I). 
 
1RM 
In paper IV 1RM was measured in the leg press machine using Olympic weights 
(Eleiko, Sweden). The lift was performed from complete extension to 90 degrees 
angle in the knee joint and back to complete extension. In paper III 1RM was 
measured as single leg knee extension. Approved lifts had to reach 160° in the knee 
joint. In all three studies/papers, the load was increased successively until the patients 
or subjects were not able to lift the weight. Rest periods were 2-3 minutes between 
each trial (American College of Sports Medicine 2010). 
 
RFD 
Measures of rate of force development were performed in paper III. Testing of RFD 
was carried out in the leg extension machine. Force parameters were measured using a 
SHB×R force transducer (Revere Transducers, California, USA). All tests were 
performed with 90° flexion in the knee joint. Dynamic peak force (PFd) and dynamic 
rate of force development (RFDd) were measured using a 27.6 kg standard load. 
Isometric peak force (PFi) and isometric rate of force development (RFDi) were 
measured during a 6 seconds maximal isometric contraction. All subjects held their 
buttocks on the seat, the hip angle steady and the back against the backrest. All 
procedures were repeated 2 or 3 times with 3 minutes rest between each trial and 
alternating between the left and right leg. RFD was calculated as the force difference 
between 10-70 % of PF divided by the time needed to achieve this difference (i.e. 
ǻforce/ǻtime).  
 
Anthropometry 
Body fat (BF) was measured using the anthropometric techniques described by 
Norton, Whittingham et al. (2002) using a Holtain Skinfold calipers (Holtain Ltd, 
Crosswell, Crymych, United Kingdom). The same exercise physiologist performed all 
measurements. Measurements were made on the right side of the upper body, at four 
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sites (biceps, triceps, sub scapular and supra-iliac areas). Procedures are described by 
Durnin and Womersley (1974) and Norton (2002). 
Quadriceps femoris muscle volume and mass was calculated for both legs by 
procedures described by Andersen and Saltin (1985) and Radegran, Blomstrand et al. 
(1999).  
Equations are presented in paper III (Heggelund et al. 2013).  
 
Psychometric variables 
Possible changes in positive and negative symptoms were assessed using the Positive 
and Negative Syndrome Scale (PANSS) (Kay et al. 1987). The test was performed by 
two psychiatric nurses, trained in using PANSS, working in the ward and had a 
personal knowledge of the patient. The Calgary Depression Scale for Schizophrenia 
(CDSS) was used to assess depressive symptoms (Addington et al. 1990). The SF-36® 
Health Survey (SF-36) was used to assess the physical health and mental health aspect 
of health related QOL (Ware et al. 2000). The SF-36 is a 36-item self-report 
instrument. 
 
Interventions 
Treadmill interval training 
The HIT group trained 4x4 minutes interval training on a treadmill (Tung Keng 
Enterprise CO., LTD. Taiwan) at 85 to 95 % HRpeak interspersed with 3 min of active 
resting periods at a work load corresponding to 70 % HRpeak between each interval, 
previously shown to be highly effective (Helgerud et al. 2007; Rognmo et al. 2004; 
Tjonna et al. 2008; Wisloff et al. 2007). Patients performed the intervals walking or 
running with a minimum of 5 % inclination. Heart rate was assessed continuously 
during exercise, using a Polar S610i heart rate monitor (Polar Electro, Finland). The 
exercise physiologist ensured that the patients performed intervals at the scheduled 
intensity.  
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Strength training 
Knee extension. Training sessions (paper III) started with a 5 min warm-up on a 
bicycle ergometer followed by 3 sets of 8-10 repetitions with a weight load 
approximately 40-50 % of 1RM in the knee-extension machine (Felax, Healthlife HG-
5114, China).  
All subjects started each training session with their dominant leg, that is, half 
of the subjects started with MST and half of the subjects with CON. After finishing 
the training in their dominant leg, subjects performed the other intervention using 
their non-dominant leg. The two training programs were equal with respect to training 
volume, hence the CON training was 3 sets of 10RM and the MST alternated each 
training session between 4 and 5 sets of 5RM (i.e. 85-95 % 1RM). MST was carried 
out using maximal mobilisation of force in the concentric muscle action. Subjects 
rested for 3 minutes between each set. CON was performed according to the 
American College of Sports Medicine (ACSM) guidelines (Ratamess et al. 2009) with 
10RM (i.e. 60-70 % of 1RM) which is considered a moderate intensity for 3 
consecutive sets with moderate velocity and 1 minute between each set. When a 
subject successfully executed the determined number of repetitions, the load was 
increased with approximately 1.25 – 2.5 kg the next training session. An experienced 
exercise physiologist supervised all training sessions. 
 
Leg press. All MST sessions started with a 5-minute warm-up on the treadmill at a 
workload corresponding to 70 % of HRpeak. MST was then performed at a 54Û incline 
leg press machine (Technogym, Italy). The weight was lowered in a controlled 
manner in the eccentric phase until the patient reached 90 degrees in the knee joint. 
Then the patients had a short stop (~0.5 second) before the weight was moved as 
rapidly as possible to complete extension. The training volume was 4 sets of 4RM 
(i.e. 85-90 % 1RM). An exercise physiologist supervised the training sessions and 
ensured that the training load was increased with 2.5-5 kg each time patients managed 
to perform 4 sets with the determined load or each training session. Rest periods were 
3 minutes between each set. 
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Computer games 
The CG group spent 36 minutes three times per week training to improve their ability 
in the computer game Tetris (THQ Inc. Calabasas Hills, CA), using an Xbox Video 
Game Systems (Microsoft Corporation, Redmond, USA). All sessions were 
monitored and patients were encouraged to improve performance. 
 
Statistical analysis 
In paper I, we used an independent samples T-test to compare differences between 
men and women, between patients below and above the VO2peak thresholds as well as 
between measured VO2peak and HUNT general and HUNT inactive VO2peak. In paper 
II, an independent samples T-test was performed to test differences at baseline and 
changes from pre- to post-test between the two groups. Due to the nature of the design 
in paper III, we used paired samples t-test to evaluate difference in pre- to post-
changes between the MST leg and CON leg. Paired samples t-tests were also used to 
determine changes from pre- to post-test in paper II and III. The normality of the 
distribution of scores was assessed using the Kolmogorov-Smirnov test and by 
evaluating the skewness and kurtosis values. 
In paper IV, a related samples Wilcoxon test was used to determine changes 
from pre- to post-intervention. Independent samples Mann-Whitney U tests were used 
to evaluate the changes and differences between groups. Categorical variables were 
tested using Fisher’s exact test. 
In paper I, we used Pearson’s chi-square tests to detect whether there was a 
significant association between patients above/below the VO2peak threshold and 
prevalence of risk factors. We calculated the odds ratio for having 1 risk factors in 
the patients below threshold. The analysis was adjusted for age and sex. In 
multiadjusted analysis, we also took into account the potential confounding effect of 
smoking. We used Pearson r to analyse correlations between VO2peak (ml·kg-0.75·min-1) 
and each domain of the SF-36.  
The significance level was set at p < 0.05 (2-tailed). Data are described as 
mean and standard deviation (SD), unless otherwise noted. SPSS statistical package, 
version 17.0 or 18.0 (SPSS Inc.), was used to analyse results.
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Paper I. Reduced peak oxygen uptake and implications for cardiovascular health and 
quality of life in patients with schizophrenia (Heggelund et al. 2011a). 
 
Background. VO2peak is a strong predictor of CVD and all-cause mortality, but is 
inadequately described in patients with schizophrenia.  
Aims. To evaluate treadmill VO2peak, CVD risk factors and QOL in patients with 
schizophrenia (ICD-10, F20-29).  
Methods. 33 patients, 22 men (33.7 ± 10.4 years) and 11 women (35.9 ± 11.5 years), 
were included. Patients’ VO2peak were compared with normative VO2peak in healthy 
individuals from the Nord-Trøndelag Health Study (HUNT). Risk factors were 
compared above and below the VO2peak thresholds; 44.2 and 35.1 ml·kg-1·min-1 in 
men and women, respectively. 
Results  
1. VO2peak was 37.1 ± 9.2 ml·kg-1·min-1 in men with schizophrenia; 74 ± 19 % of 
normative healthy men (p < 0.001; figure 4).  
2. VO2peak was 35.6 ± 10.7 ml·kg-1·min-1 in women with schizophrenia; 89 ± 25 
% of normative healthy women (n.s.; figure 4).  
Based on the odds ratio patients were 28.3 (95 % CI=1.6-505.6) times more likely to 
have 1 CVD risk factors if they were below the VO2peak thresholds. VO2peak 
correlated with the SF-36 physical functioning (r = 0.58), general health (r = 0.53), 
vitality (r = 0.47), social function (r = 0.41) and physical component (r = 0.51) scores. 
Conclusion. Men with schizophrenia have lower VO2peak than the general population. 
Patients with the lowest VO2peak have higher odds of having 1 risk factors for CVD. 
VO2peak should be regarded as at least as important as the conventional risk factors for 
CVD and evaluation of VO2peak should be incorporated into clinical practice.  
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Figure 4. Peak oxygen uptake in patients with schizophrenia and normative healthy men and 
women. Normative strata are taken from the HUNT fitness study (Aspenes et al. 2011). HUNT general 
strata are age and sex specific strata regardless of physical activity level. Figure taken from paper I 
(Heggelund et al. 2011a). 
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Paper II. Effects of high aerobic intensity training in patients with schizophrenia: a 
controlled trial (Heggelund et al. 2011b). 
 
Background. Patients with schizophrenia have a high risk of CVD. HIT improves 
VO2peak, İnet of walking and risk factors for CVD, but these are not investigated in 
patients with schizophrenia.  
Aims. To investigate the effects of HIT on VO2peak, İnet and the risk factors for CVD 
in patients with schizophrenia.  
Methods. 25 inpatients (F20 to 29, ICD-10) were allocated to either HIT or CG, three 
days per week for eight weeks. HIT consisted of 4x4 minutes intervals with 3 minute 
rest periods at 85 to 95 % and 70 % of peak heart rate, respectively. 
Results. 
1. 12 and 7 patients completed HIT and CG respectively.  
2. The HIT group improved VO2peak by 12 % from 3.17 ± 0.59 L·min-1 to 3.56 ± 
0.68 L·min-1 (p < 0.001; figure 5), more than the CG group (p = 0.014).  
3. İnet improved by 12 % in the HIT group from 19.8 ± 3.0 % to 22.2 ± 4.5 % (p 
= 0.005; figure 5), more than the CG group (p = 0.031).  
4. The psychiatric symptoms, expressed as PANSS and CDSS, did not improve 
in either group. 
 
Conclusions: VO2peak and İnet improved significantly from 8 weeks of HIT. HIT 
should be included in rehabilitation in order to improve physical capacity and 
contribute to reducing the risk of CVD. 
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Paper III. Maximal strength training improves work economy, rate of force 
development and maximal strength more than conventional strength training 
(Heggelund et al. 2013). 
 
Background. MST improves work economy but it is not known whether CON would 
result in the same improvements.  
Aims. To compare MST with equal training volume of CON primarily with regard to 
work economy, and secondly 1RM and RFD of single leg knee-extension.  
Methods. In an intraindividual design, one leg was randomized to knee-extension 
MST (4 or 5×5 repetitions, 85-90 % 1RM) and the other leg CON (3×10 repetitions, 
70-75 % 1RM) 3 times per week for 8 weeks. MST was performed with maximal 
concentric mobilisation of force while CON was performed with moderate velocity. 
Results. 
1. A significant difference in change were noted between training 
conditions in Cke (ml·kgm-1·min-1; p < 0.024). Cohens’d was >0.8 or 
higher for between groups differences, indicating a large effect in 
favour of the MST. 
2. The gross work economy was improved with -0.10 ± 0.08 L·min-1 
more after MST compared to CON (p = 0.011, between legs).  
3. From pre-to post-test the MST and CON improved work economy with 
31 % (p < 0.001) and 18 % (p = 0.01) respectively.  
4. Compared to CON, the improvement in 1RM and RFDd was 13.7 ± 
8.4 kg (p = 0.002) and 587 ± 679 N·s-1 (p = 0.044) larger after MS
whereas the improvement in RFD
T 
i was of borderline significance 3028 
± 3674 N·s-1 (p = 0.053).  
5. MST improved 1RM and RFDi from pre- to post-test by 50 % (p < 
0.001) and 155 % (p < 0.001) respectively.  
6. CON improved 1RM and RFDi with 35 % (p < 0.001) and 83 % (p = 
0.028) respectively.  
7. Anthropometric measures of quadriceps femoris muscle mass and 
VO2peak did not change.  
 
Conclusions. Eight weeks of MST was more effective than CON for improving work 
economy, 1RM and RFD in untrained and moderately trained men. The advantageous 
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effect of MST on improvements in work economy could be due to a larger 
improvement in 1RM and RFD.  
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Paper IV. Therapeutic effects of maximal strength training on walking efficiency in 
patients with schizophrenia (Heggelund et al. 2012). 
 
Background. Patients with schizophrenia frequently have disabling gait deficits. İnet 
is an accurate measure often used to evaluate walking performance. Patients with gait 
deficits have a reduced İnet with excessive energy expenditure during sub-maximal 
walking. MST improves İnet in healthy individuals and is associated with a reduced 
risk of mortality.  
Aims. The aim of this study was to investigate whether MST improves İnet in patients 
with schizophrenia.  
Methods. Patients (ICD-10 schizophrenia, schizotypal or delusional disorders [F20-
F29]) were included in a non-randomised trial. Patients were assigned to one of two 
groups: 1) MST consisting of 4 x 4RM performed in a leg press apparatus or 2) CG. 
Both groups carried out their activity three days per week for eight weeks. 1RM, İnet 
at 60 watt walking, VO2peak, PANSS and the SF-36 were measured pre- and post-
intervention. 
Results. 
1. The baseline İnet was 17.3 % ± 1.2 % and 19.4 % ± 3.0 % in the MST 
(n = 6) and CG groups (n = 7), respectively, which is categorised as 
mechanical inefficiency.  
2. The MST group improved 1RM by 79 kg (p = 0.006) and İnet by 3.4 % 
(p = 0.046) more than the CG group.  
3. The MST group improved 1RM and İnet, by a mean of 83 kg (i.e. 38 % 
change) (p = 0.028) and 3.4 % (i.e. 20 % change) (p = 0.028) 
respectively (figure 5).  
4. VO2peak at baseline was 34.2 ± 10.2 and 38.3 ± 9.8 ml·kg-1·min-1 in the 
MST and CG groups respectively, and did not change (p > 0.05; figure 
5).  
5. No change was observed in PANSS or SF-36 (p > 0.05). 
 
Conclusions. MST improves 1RM and İnet in patients with schizophrenia. MST could 
be used as a therapeutic intervention for patients with schizophrenia to normalise their 
reduced İnet. 
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Figure 5. Percent pre-to post-changes of peak oxygen uptake (VO2peak), net mechanical efficiency 
of walking (İnet) and one repetition maximum (1RM) across interventions in study II and IV. 
#different from CG group; p < 0.05, **difference between pre- and post-test p < 0.01, *** difference 
between pre- and post-test p < 0.001. Values are mean ± standard error (SE). 
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5. Discussion across papers 
 
The main findings of the thesis are;  
1. Men and women with schizophrenia have only 74 % and 89 % of the 
VO2peak of normative men and women, respectively (paper I).  
2. Patients with a VO2peak below 44.2 ml·kg-1·min-1 (men) and 35.1 ml·kg-
1·min-1 (women) were 28.3 times more likely to have 1 risk factors for 
CVD (paper I). 
3. VO2peak correlates with the patients’ perception of physical function, 
general health, vitality, social function and SF-36 physical component 
score (paper I). 
4. The patients with schizophrenia had a İnet of walking that is 
categorised as mechanical inefficiency (i.e. reduced) (paper II and IV).  
5. High aerobic intensity training improved VO2peak (12 %) and İnet (12 
%) in patients with schizophrenia (paper II). 
6. MST was superior to CON in improving work economy (otherwise 
known as İnet) (paper III).  
7. MST improved 1RM (38 %) as well as İnet (20 %) in patients with 
schizophrenia (paper IV). 
 
Reduced physical fitness as a predictor of CVD and premature 
mortality 
In paper I we found that VO2peak in men with schizophrenia was 74 ± 19 % of healthy 
men (p < 0.001), whereas women with schizophrenia had a VO2peak that was 89 ± 25 
% of healthy women (n.s.). Even more importantly, based on the odds ratio patients 
were 28.3 (95 % CI=1.6-505.6) times more likely to have 1 CVD risk factors if they 
were below the VO2peak thresholds presented by Aspenes et al. (2011) in the HUNT 
fitness study. The present study found a very low VO2peak in patients with 
schizophrenia and a high frequency of risk factors for CVD among patients with low 
VO2peak. Two resent studies confirmed this finding (Scheewe et al. 2012b; Strassnig et 
al. 2011). 
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High risk of CVD in patients with schizophrenia has been consistently 
reported during the latest decades. The evidence is mainly derived from 
epidemiological studies concentrated on the high mortality and the causes of the 
excess mortality as an outcome (Osby et al. 2000; Brown et al. 2000).  
It is well known that exercise cause beneficial adaptations that reduce the risk 
of CVD. Though, early exercise research was often concentrated on the hypotheses as 
to whether exercise could improve mental health variables and seldom applied high 
quality measures of physical fitness and cardiovascular risk factors (Adams 1995; 
Belcher 1988; Carter-Morris and Faulkner 2003; Chamove 1986; Faulkner and 
Sparkes 1999; Gimino and Levin 1984; Hatlova and Basny sen 1995; Lukoff et al. 
1986; Mrazek and Hatlova 1995; Pelham et al. 1993; Rosenthal and Beutell 1981). 
These studies did not incorporate highly effective training interventions to improve 
fitness (Wildgust et al. 2010) and they had methodological issues that reduced the 
quality (Faulkner 2005). This trend has changed during the recent years. Now a 
number of exercise studies in patients with schizophrenia have been conducted, some 
have a high methodological quality and the studies’ aims are often to reduce the high 
risk of CVD (Scheewe et al. 2012c; Scheewe et al. 2012b; Strassnig et al. 2011; 
Pajonk et al. 2010; Blouin et al. 2009; Pajonk et al. 2008; Heggelund et al. 2011a; 
Heggelund et al. 2012; Heggelund et al. 2011b).  
The epidemiological studies of CVD risk in patients with schizophrenia point 
at obesity and overweight, hyperglycemia, dyslipidemia, hypertension and smoking as 
major risk factors (Hennekens et al. 2005). Although these are indisputable 
contributors to the high CVD risk, several studies now suggest that these variables are 
indirect manifestations of poor exercise capacity (Kavanagh et al. 2002; Kodama et al. 
2009; Myers et al. 2002). VO2peak is often a stronger predictor of mortality than 
conventional risk factors for CVD (Myers et al. 2002). McAuley and Blair (2011) 
recently pointed out that reduced cardiorespiratory fitness is as a greater health threat 
than obesity and suggested that more emphasis should be put on increasing VO2peak. 
Higher levels of VO2peak seem to attenuate or eliminate the increased health risk 
associated with obesity (Lee et al. 2005). Findings from the HUNT study demonstrate 
that physical active people with a clustering of cardiovascular risk factors appear to 
have comparable risk of premature death as inactive individuals without risk factors 
(Tjonna et al. 2010). In the same cohort, men with VO2peak below 44.2 ml·kg-1·min-1 
 
 37
5. Discussion across papers 
 
were eight times more likely to have a cluster of CVD risk factors, compared to men 
above 50.5 ml·kg-1·min-1 (Aspenes et al. 2011).   
The association between physical fitness and risk of CVD is often described in 
relation to VO2peak. However, muscular strength is an additional risk factor and its 
relationship to the risk of CVD is independent of VO2peak and body mass index (Jurca 
et al. 2004; Ortega et al. 2012; Ruiz et al. 2008). Muscular strength is inversely 
associated with CVD and all-cause mortality (Ruiz et al. 2008; Ortega et al. 2012) and 
the prevalence of metabolic syndrome (Jurca et al. 2004). Stronger individuals likely 
have increase resting metabolic rate, increase muscle mass and reduced total and 
abdominal fat (Tresierras and Balady 2009). Strength is also associated with insulin 
sensitivity, glucose tolerance and diastolic blood pressure (Pollock and Vincent 1996). 
The data collected in this thesis do not allow for comparison with 1RM levels in the 
general population.  
 
Reduced physical fitness associated with low QOL 
In paper I, we reported that the VO2peak correlated with the patient’ perceptions of 
physical function, general health, vitality, social function, and physical component 
score. With some exceptions, these findings are consistent with correlations between 
SF-36 variables and BMI in patients with schizophrenia (Strassnig et al. 2003). In line 
with Strassnig, Brar et al. (2003) we found a significant correlation with the physical 
component score but not the mental component score, suggesting that reduced 
VO2peak mainly is perceived as a physical health problem, not mental. Conversely, 
both the mental and physical health components of QOL are found to be related to 
estimated VO2peak in healthy men (Sloan et al. 2009). Interestingly, the patients w
lower VO
ith 
ntary 2peak seemed to experience lower vitality and social functioning. A sede
lifestyle is associated with greater risk of low vitality (Puetz 2006). 
The patients’ perceptions of their QOL in the SF-36 self report measure tended 
to be better than expected. Severely ill patients with schizophrenia are said to have 
problems in evaluating QOL and their scores tend to differ from those of their carer 
(Linaker and Moe 2005). 
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Walking inefficiency in patients with schizophrenia 
Papers II and IV are the first published studies that have measured İnet of walking in 
patients with schizophrenia. Poor İnet is analogous with excessive energy expenditure 
and physical fatigue. The findings revealed a mechanical inefficiency of walking in 
patients with schizophrenia. The mechanism for this walking inefficiency is not 
known, but it may likely be related to the gait deficits observed in schizophrenia. The 
fact that gait deficits such as those in Parkinson’s disease reduce İnet, suggests a 
similar relationship for those with schizophrenia (Christiansen et al. 2009).  
 
Effects from HIT and MST on VO2peak in patients with schizophrenia 
In paper II we evaluated the effects of HIT in patients with schizophrenia. The HIT 
training program was developed with the distinct aim of improving VO2peak. The 
comparisons of HIT with other endurance training regimes are documented elsewhere 
(Helgerud et al. 2007; Rognmo et al. 2004; Wisloff et al. 2007), but the effect of this 
particular program was not tested in patients with schizophrenia. In paper II, the HIT 
group improved VO2peak by 12 % by adhering to 85 ± 9 % of the scheduled training 
sessions. Similar sizes of improvement are found in healthy controls and in patients 
with CVD (Helgerud et al. 2007; Rognmo et al. 2004; Wisloff et al. 2007). However, 
neither CG nor MST (in paper IV) improved VO2peak (figure 2). Although this was not 
surprising, it illustrates that HIT should be given particular attention in the treatment 
program to improve VO2peak. Neither CG nor MST overloads the oxygen transport 
system sufficiently to give any adaptations in VO2peak.  
 It seems fair to conclude that VO2peak is a trainable property in patients with 
schizophrenia as for healthy individuals. For patients with schizophrenia the 
trainability of VO2peak is largely related to their ability to adhere to the HIT. The 
patients included in the present study were inpatients that suffered from severe 
schizophrenia. The majority of the patients had several years of hospitalisation and 
some were described as treatment resistant. In spite of the severity of their illness, 
they managed to participate in HIT and improve VO2peak within a short period.  
 Other types of endurance training programs may also improve VO2peak, at least 
in the first months of a training program (Pajonk et al. 2010; Scheewe et al. 2012a; 
Scheewe et al. 2012b). The benefit of HIT is the larger improvement, due to training 
at a high aerobic intensity. Considering the high risk of CVD and the challenging task 
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of motivating patients with schizophrenia to exercise, the effectiveness of the 
intervention ought to be considered. Additionally, training with intervals at a high 
aerobic intensity is found to be more enjoyable than moderate intensity at a constant 
pace (Bartlett et al. 2011). These issues could have important implications for the 
adherence to exercise training and the long-term prevention of low VO2peak in patients 
with schizophrenia.  
 
Strength training to improve 1RM, RFD and work economy (or İnet)   
In paper III we compared two 8-weeks resistance training programs on effects on 
work economy, maximal strength and explosive strength. Paper III is part of the 
strategy to develop the resistance training program that we planned to use in paper IV. 
To compare these two resistance training programs we used an intraindividual design 
and an equivalent volume of training. The main finding was that MST was superior to 
CON based on the primary outcome variables.    
MST improved 1RM and RFD and work economy, by using heavy loads (>85 
% of 1RM), few repetitions (5), maximal mobilisation of force in the concentric part 
of the movement in combination interspersed with long resting periods (>3 minutes) 
(Bird et al. 2005; Campos et al. 2002; Cormie et al. 2011). For untrained and 
moderately trained individuals, it is generally recommended to apply CON; i.e. 
moderate loads corresponding to 60-70 % of 1RM for a repetition range of 8-12 
performed with slow to moderate velocities (Ratamess et al. 2009). Paper III is the 
first study that aimed to clarify whether CON could attain the same profitable benefits 
(in work economy, 1RM, RFD) as found after heavy, explosive strength training (i.e. 
MST).   
Work economy improved by 31 % and 18 % after MST and CON 
respectively. The improvements were large but they were in agreement with others 
(Hoff et al. 2002; Hoff et al. 1999; Osteras et al. 2002; Storen et al. 2008; Sunde et al. 
2010; Wang et al. 2010). 1RM improved in MST and CON by 50 % and 35 % 
respectively. MST improved maximal strength substantially and statistically 
significantly more than CON. This is in agreement with the findings from Campos, 
Luecke et al. (2002) that 3-5RM in 4 sets and 3 minutes rest periods was more 
effective than 9-11RM for 3 sets and 2 minutes rest periods. Both groups also 
improved PF and RFD in both the dynamic and isometric muscle actions. The change 
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was larger after MST for all variables apart from the RFDi, which was of borderline 
significance, and the effect sizes are favourable towards MST. This is in line with 
Behm and Sale (1993) who suggested that the intentional velocity is more important 
than the actual velocity. However, CON, with moderate repetition velocity also 
improved RFD, although to a lesser extent than MST.   
Paper III indicates that a resistance-training program that is most effective in 
improving maximal strength and RFD is superior for improving work economy. As 
all variables improved in both conditions, it seems reasonable that mechanisms 
responsible for the underlying improvement in work economy were similar for the 
two interventions although of a greater magnitude with MST. 
From the findings of paper III, we choose to apply the MST program in 
patients with schizophrenia (paper IV). This option was based on the suggestion that 
the findings from paper III also would apply to patients with schizophrenia. Paper III 
also suggested that CON would have beneficial responses in patients with 
schizophrenia, but these were not pursued further. The empirical rationale suggests 
that a broader range of strength training methods is beneficial. Thus, trainers have 
some freedom when gradually introducing the most effective intervention to patients 
that might struggle to accommodate an optimal training regimen.  
 
Effects from HIT and MST on 1RM and work economy (or İnet) in 
patients with schizophrenia 
In this thesis, we applied two interventional strategies to improve İnet. In paper II, we 
found that HIT improved İnet by 12 % whereas maximal strength was not affected 
(figure 2). On the contrary, in paper IV we found that MST improved İnet by 20 % 
along with a large improvement in maximal strength (figure 2). As HIT improves İnet, 
part of the walking inefficiency in schizophrenia must be caused by inactivity. 
However, MST seems to improve İnet more than HIT, in absolute terms. As suggested 
in paper III, this favourable change may be elicited by improved maximal strength 
and explosive strength. 
Our findings are similar to those found with other patients who suffer from 
poor İnet, such as those with coronary artery disease, peripheral arterial disease, 
chronic obstructive pulmonary disease and patients operated with total hip 
arthroplasty, that have derived benefit from lower limb MST (Husby et al. 2009; 
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Karlsen et al. 2009; Wang et al. 2010; Hoff et al. 2007). Improved maximal strength 
and explosive strength have significant carry-over effects on walking performance 
measured as İnet (Karlsen et al. 2009; Wang et al. 2010; Husby et al. 2009; Hoff et al. 
2007). 
 
HIT and MST to reducing the risk of CVD 
Improved VO2peak and 1RM confirmed the reduced risk of CVD in papers II and IV. 
There were no changes in the conventional risk factors for CVD during the 
intervention (paper II). The mean blood pressure, triglyceride, hs-CRP, total-
cholesterol and glucose were within normal values. While targeting this risk factor of 
CVD it may be important to emphasise improvements in 1RM and VO2peak even if the 
conventional risk factors do not respond in the short term (Lee et al. 2005). Fitness in 
terms of 1RM and VO2peak offer a protective effect from other risk factors that 
independently would reduce the risk of CVD and all cause mortality (Lee et al. 2005). 
Physical activity and exercise training are considered effective therapies for 
improving the cardiovascular risk factor profile in patients with CVD, hypertension, 
metabolic syndrome and diabetes (Regensteiner and Hiatt 2002; Leon et al. 2005; 
Gordon et al. 2004; Khan et al. 2009). The general benefits of aerobic exercise 
training include reduced blood pressure, improved blood lipid profile, decreased 
systemic inflammation with accompanying reduction in atherosclerosis (Janssen 
2012, p. 190). Aerobic exercise also improves endothelial function, vasoconstriction 
properties and has an antithrombotic effect (Janssen 2012, p. 190). These 
improvements are considered plausible mechanisms by which exercise reduced the 
risk of CVD. Similarly, strength training promotes metabolic health (Magyari and 
Churilla 2012). Strength training improves glucose metabolism, cholesterol levels, 
blood pressure and basal metabolic rate (Pollock and Vincent 1996). These changes 
are thought to reduce the CVD risk factors and the prevalence of metabolic syndrome 
(Williams et al. 2007). The strength training program is however probably dependent 
on higher total training volume (several exercises) than that in paper IV to allow 
significant adaptations to the CVD risk factor profile. A combination of HIT and MST 
may be an overall effective strategy to affect both strength and cardiovascular 
mechanisms in patients with schizophrenia (Stensvold et al. 2010). Both training 
modalities independently benefit cardiovascular risk (Schjerve et al. 2008; Stensvold 
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et al. 2010). Therefore, program design would allow some individual adjustments to 
assist patients struggling with motivation to exercise. 
Training intensity, as in HIT, tends to be crucial to reverse risk factors. HIT is 
found to elicit greater improvements in endothelial function, insulin signalling, 
skeletal muscle biogenesis, blood glucose and lipogenesis than that found after 
moderate intensity endurance training (Tjonna et al. 2008; Wisloff et al. 2007; 
Schjerve et al. 2008). 
 
Effects of HIT and MST on symptoms and QOL in patients with 
schizophrenia 
In paper II and IV, no significant changes in PANSS, CDSS or in SF-36 were found 
after HIT, MST or CG. Thus, our findings do not support the idea of exercise as a 
treatment for symptoms of schizophrenia. In absolute terms, there was an increase of 
10 points in the MST group (paper IV), a decrease of 2 points in the HIT group (paper 
II) and a decrease of 2 points in the CG group (papers II and IV) on the total PANSS 
score. We suggested this tendency of a change is due to natural variations in the 
course of the illness and is probably expected for patients with schizophrenia.  
The hypothesis of whether exercise training has an impact on symptoms of 
schizophrenia has been discussed in the literature. Although, with some limitations in 
methodology in early studies, Faulkner (2005) concluded in his review that exercise 
could alleviate some of the positive and negative symptoms of schizophrenia. 
Moreover, important psychological benefits may be observed in patients in addition to 
those of a diagnostic character (Faulkner 2005). In brief, patients may: display less 
psychotic features on days of exercise (Chamove 1986), use exercise as a coping 
strategy to control auditory hallucinations (Carter-Morris and Faulkner 2003; 
Faulkner and Sparkes 1999), improve social interest and self-esteem (Adams 1995; 
Carter-Morris and Faulkner 2003; Chamove 1986), improve body image (Rosenthal 
and Beutell 1981), improve sleep pattern (Faulkner and Sparkes 1999), and reduce 
depression and anxiety (Chamove 1986; Faulkner and Sparkes 1999; Gimino and 
Levin 1984; Pelham et al. 1993). Patients may also improve their daily functioning 
level expressed as hygiene and pursuit of appropriate independence (Perham and 
Accordino 2007). The conclusion by Faulkner (2005) that exercise may improve 
chronic symptoms of schizophrenia recently achieved support from a larger 
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randomised trial (Scheewe et al. 2012a). Scheewe and colleagues (2012a) found that 
the patients participating an a 6 months exercise therapy reduced their total PANSS 
score (-20.7 %) compared to occupational therapy (+3.3 %). Only a small proportion 
of these patients were inpatients. Another study found that total PANSS improved 
somewhat in a cycling exercise group (-9 %) and worsened in a nonexercise group 
(+13 %) after 3 months (Pajonk et al. 2010). Additionally, Beebe and colleagues 
(2005) reported an absolute improvement (non-significant) in the total PANSS score 
after 16 weeks of exercise. Beside slight differences between interventions and 
sample characteristics, these three latter studies lasted for a longer period than our 8 
week interventions. 
The effects of resistance training in patients with schizophrenia are poorly 
investigated. A single-group study found that patients reported improvement in a 
questionnaire that measured perceived psychological well being, but no improvement 
in the Zung Self Rating Depression Scale, after weight lifting therapy (Auchus and 
Kaslow 1994). A case study described some improvements in Brief Psychiatric Rating 
Scale (BPRS) and the Nurses’ Observational Scale for In-Patient Evaluation (Adams 
1995). Clearly, there is a need for larger scale and longitudinal intervention studies on 
the impact of resistance training exercise in patients with schizophrenia.  
In patients with chronic schizophrenia already receiving much psychosocial 
support, it might be difficult to demonstrate improvement in symptoms or in 
psychosocial function with an 8-week physical training intervention. The patients 
included in our studies (papers I, II and IV) had severe schizophrenia, the majority of 
the patients had several years of hospitalisation and some were described as treatment 
resistant. In spite of the severity of their illness, they managed to complete the 8-week 
exercise training periods. 
 
Thesis limitations 
In two studies (papers II and IV), the allocation of patients to groups were non-
randomised. Non-randomised trials might overestimate changes (Schulz et al. 1995). 
The decision was a trade-off between accepting the limitations of the non-randomised 
groups design and achieving the benefits of including more patients. Many patients, 
and particularly those with a high level of negative symptoms, might have difficulties 
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in attending randomised trials (Abbott et al. 2005; Beebe et al. 2005; Correll et al. 
2011).  
To reduce the selection bias we ensured that all patients were eligible for all 
three interventions. None of the patients were selected because they fitted one of the 
groups more than they fitted the other. Moreover, the patients were not able to choose 
a particular group. It was not possible to control for potential unknown confounders 
such as months since last hospitalisation (outpatients), fluctuating symptoms, previous 
exercise experience, drug abuse, type and/or amount of psychiatric services et cetera. 
Nevertheless, there were no statistically differences between groups on demographic 
variables at baseline.  
It is appropriate to discuss whether a randomised controlled trial on exercise 
can be performed in seriously ill patients with schizophrenia. In the recruitment 
process, we noticed that patients were insecure about attending the study. To make 
them feel confident, we had to explain into detail what they were supposed to do 
during tests and exercise. These explanations were vital in helping patients to feel 
secure and finally consent to participate in the study. Without giving them this 
security, many would not participate or withdraw from the study. We had to tell them 
about the intervention and therefore, the studies (paper II and IV) were not 
randomised. Two other research groups managed to carry out a randomised controlled 
trial in patients with schizophrenia (Pajonk et al. 2010; Scheewe et al. 2012b). 
Contrary to the present studies (papers II and IV), a large proportion of the patients 
were outpatients. 
The short 8-week interventions (paper II and IV) might be too short a period, 
particularly for patients suffering from schizophrenia, to induce change in certain 
psychiatric and metabolic parameters. 
Employing an intraindividual design (paper III) with unilateral training may 
obviously have caused cross education. Cross education is at least partly caused by 
enhanced neural drive to the contra lateral agonist muscle (Fimland et al. 2009). This 
could have been precluded by using a control group. However, we consider this 
disadvantage to be outweighed by the fact that there is a considerable inter-individual 
variation to strength training adaptations. In addition, the magnitude of the cross-
education depends on the improvement in the trained leg. Hence, the improvements 
after CON might have been increased by the greater improvements of the MST leg. 
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Future perspectives  
The benefits of exercise training therapy in patients with severe mental illnesses are 
substantially documented but many may be unexploited. Exercise combines the 
physiological and psychological aspect of health and holds the potential to prevent 
and cure many of the illnesses related to inactivity. Exercise influences the body-mind 
connection through many known mechanisms and improves several aspects of mental 
health (Faulkner 2005). Moreover, the improved exercise capacity provides a basis 
that renders possible the performance of day-to-day activities.  
Exercise therapy is not a stand-alone treatment for patients with schizophrenia 
but a therapy that should be integrated in the conventional treatment to achieve the 
quality of care in terms of preventive, curative, palliative treatment and disease 
management. Exercise therapy has distinct adaptations that patients may not achieve 
through other treatment modalities. However, there is a lack of knowledge on how 
exercise can be combined and adapted with the conventional treatments.  
The distinct benefits of exercise, including the reduction of CVD risk, need 
further address. There are multiple risk factors for CVD in schizophrenia and the 
particular role of exercise appears to be an effective strategy. Theoretically, we 
assume that participation in exercise therapy with resulting improvement in fitness 
increases the likelihood to sustain good health, but how this translates into CVD 
prevalence and mortality rates should be investigated in a longitudinal study.  
The potential influence of exercise therapy on general psychopathology, and 
positive, negative and cognitive symptoms of schizophrenia should be further 
addressed. Whether the described effect in some studies is a result of a specific 
intervention, confounding variables or natural variation, is worthy of further 
study/investigation. Effects of longitudinal exercise therapy interventions on 
symptoms of schizophrenia could be tested in a prospective design. HIT and MST 
should be compared to other exercise modalities to define effective interventions and 
dose-response relationships. Moreover, there are rather conflicting results on whether 
the physical activity level or the fitness level contributes the most to the mental health 
benefits. The improvements in certain fitness variables tend to be central for physical 
health improvements. It is possible that the relationship to mental health variables 
follows a similar pattern.   
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Regardless of the potential treatment effect on symptoms of schizophrenia, 
probably the most important aspect for the patients is how they can manage to cope 
with their illness, integrate to community and ensure a lower risk of CVD. Whether 
these effects are possible with exercise interventions is due to be addressed in a larger 
prospective study. Low aerobic capacity might have adverse effects that could hamper 
the reintegration into the community, reduce adherence to other treatment regimens, 
and have harmful effects on QOL and physical functioning (Faulkner 2005). Thus, 
HIT might help the patients to function better and cope with their illness. 
The difficulty of recruiting patients to randomised controlled trials is an 
obstacle that ought to be considered when planning a randomised controlled trial. 
Randomisation has been shown to be possible in patients with schizophrenia referred 
to exercise. In addition, adherence to exercise is another obstacle. Separate 
interventions to improve adherence such as motivational interviewing, may be worth 
exploring. 
In paper IV, we found that MST improved 1RM along with a corresponding 
improvement in walking economy/İnet. However, we did not measure explosive 
strength (e.g. RFD). Explosive strength may have particular benefits in patients with 
schizophrenia considering the motor symptoms and walking deficit. Still, the 
responsiveness of resistance training on explosive strength in patients with 
schizophrenia is unknown. A smaller improvement in explosive strength may explain 
why the improvement in İnet in paper IV was not as large as the improvements 
reported in healthy individuals. 
 
Practical implications 
Patients with schizophrenia suffer a high risk of CVD and neurological abnormalities 
such as walking deficits. These physical illnesses reduce QOL, the ability to carry out 
day-to-day activities and comply with treatment. From this thesis, it is evident that a 
reduced VO2peak in part explains the high risk of CVD. Reduced VO2peak is a strong 
predictor of CVD and all-cause mortality. By taking part in HIT and MST, patients 
with schizophrenia could improve health and reduce the risk of CVD. Furthermore, 
VO2peak and İnet are major determinants of endurance performances. In real life, these 
performances may range from athletic competitions and all out performances to day-
to-day activities in patients with reduced physical fitness. In patients with 
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schizophrenia, the VO2peak and İnet is at a level that challenges the performance of 
physical activities and may lead to reduced QOL. This thesis clearly advocates HIT 
and MST to improve VO2peak and İnet. Importantly, after a training period, a patient 
with schizophrenia would have the ability to perform more work or to perform the 
same amount of work with reduced effort. This would likely have significant practical 
implications for the reintegration into community, adherence to medical treatments 
and therapy, and normalisation of physical health and fitness.  
HIT and MST are safe and effective interventions to improve VO2peak, 1RM 
and İnet in patients with schizophrenia
48
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6. Conclusions 
 
Men with schizophrenia have lower VO2peak than men in the general population. 
Patients with a VO2peak below 44.2 ml·kg-1·min-1 (men) and 35.1 ml·kg-1·min-1 
(women) have higher odds of having 1 risk factors for CVD than patients above the 
44.2 and 35.1 ml·kg-1·min-1 thresholds. Low VO2peak also compromises patients’ 
perceived physical health. Therefore, VO2peak should be regarded as at least as 
important as the conventional risk factors for CVD and evaluation of VO2peak should 
be incorporated in clinical practice.  
The patients with schizophrenia have poor İnet and spend excessive energy 
during walking.  
HIT can effectively improve VO2peak and net İnet during 8 weeks in patients 
that adhere to training.  
MST is more efficient than CON in improving work economy of single leg 
knee-extension, maximal strength and RFD for moderately trained healthy men in an 
eight-week intervention. 
Those patients with schizophrenia who adhere to MST improve their 1RM to 
the same level as has been observed in other patient groups and in healthy controls. 
MST also improves İnet and thus the patients’ ability to normalise their walking. 
No significant changes in symptoms of schizophrenia or QOL were found 
after 8 weeks of HIT or MST.  
Treatment for schizophrenia should include HIT and MST to contribute to 
reduce the risk associated with poor physical ability such as inactivity related 
mortality.
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Reduced peak oxygen uptake and implications
for cardiovascular health and quality of life in
patients with schizophrenia
Jørn Heggelund1,2,3*, Jan Hoff4,5†, Jan Helgerud4,6,7†, Geir E Nilsberg3† and Gunnar Morken1,3†
Abstract
Background: Peak oxygen uptake (VO2peak) is a strong predictor of cardiovascular disease (CVD) and all-cause
mortality, but is inadequately described in patients with schizophrenia. The aim of this study was to evaluate
treadmill VO2peak, CVD risk factors and quality of life (QOL) in patients with schizophrenia (ICD-10, F20-29).
Methods: 33 patients, 22 men (33.7 ± 10.4 years) and 11 women (35.9 ± 11.5 years), were included. Patients
VO2peak were compared with normative VO2peak in healthy individuals from the Nord-Trøndelag Health Study
(HUNT). Risk factors were compared above and below the VO2peak thresholds; 44.2 and 35.1 ml·kg
-1·min-1 in men
and women, respectively.
Results: VO2peak was 37.1 ± 9.2 ml·kg
-1·min-1 in men with schizophrenia; 74 ± 19% of normative healthy men (p <
0.001). VO2peak was 35.6 ± 10.7 ml·kg
-1·min-1 in women with schizophrenia; 89 ± 25% of normative healthy women
(n.s.). Based on odds ratio patients were 28.3 (95% CI = 1.6-505.6) times more likely to have one or more CVD risk
factors if they were below the VO2peak thresholds. VO2peak correlated with the SF-36 physical functioning (r = 0.58),
general health (r = 0.53), vitality (r = 0.47), social function (r = 0.41) and physical component score (r = 0.51).
Conclusion: Men with schizophrenia have lower VO2peak than the general population. Patients with the lowest
VO2peak have higher odds of having one or more risk factors for cardiovascular disease. VO2peak should be regarded
as least as important as the conventional risk factors for CVD and evaluation of VO2peak should be incorporated in
clinical practice.
Background
Patients suffering from schizophrenia have a mortality
risk that is two to three times that of the general popu-
lation and the leading cause of death is cardiovascular
disease (CVD) [1,2]. Although, multifactor causes have
been identified, reduced cardiorespiratory fitness has
probably been overlooked as a risk factor for CVD in
patients with schizophrenia [3].
Cardiorespiratory fitness, measured as peak oxygen
uptake (VO2peak) is a strong predictor of CVD and all-
cause mortality [4,5]. Improvements in VO2peak have
indicated reduced risk of CVD, coronary heart disease
and all cause mortality [5]. VO2peak is often a stronger
predictor of mortality than conventional risk factors for
CVD [6]. McAuley and Blair [7] recently pointed out
reduced cardiorespiratory fitness as a greater health
threat than obesity and suggested that more emphasis
should be put on increasing VO2peak. This might be
especially important considering that higher levels of
VO2peak seems to attenuate or eliminate the increased
health risk associated with obesity [8]. Findings from the
epidemiological Nord-Trøndelag Health Study (the
HUNT Study) demonstrate that physical active people
with a clustering of cardiovascular risk factors appears
to have comparable risk of premature death as inactive
individuals without risk factors [9]. In the same cohort
men with VO2peak below 44.2 ml·kg
-1·min-1 were eight
times more likely to have a cluster of CVD risk factors,
compared to men above 50.5 ml·kg-1·min-1 [10].
Results from the Aerobics Center Longitudional Study
further suggest that people with low VO2peak is
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characterized by depressive symptoms and low emo-
tional well being [11]. High levels of VO2peak are asso-
ciated with high levels of quality of life (QOL) [12].
Body mass index (BMI) are found inversely related to
QOL in patients with schizophrenia [3] but the relation
between VO2peak and perceived QOL are not evaluated.
Objective measures of VO2peak have rarely been pre-
sented in patients with schizophrenia. The classical
study by Carlson et al. [13] were the first to describe
oxygen uptake in patients with schizophrenia, but many
of their patients did not reach values close to maximal
oxygen uptake. Our research group revealed significant
changes in VO2peak after eight weeks of high aerobic
intensity training in patients with schizophrenia [14].
Recently, Strassnig et al. [3] published measures of oxy-
gen uptake in 117 patients with schizophrenia that were
exceedingly low (4.4 metabolic equivalents ≈ 15.4 ml·kg-
1·min-1). This VO2peak value are much lower than the
VO2 required for walking in patients with schizophrenia
[14], and at a level that may indicate a need for heart
transplant in heart failure patients [15].
The primary aim of this study was to evaluate objec-
tively measured VO2peak during walking or running in
men and women with schizophrenia compared to
VO2peak in healthy individuals from the Nord-Trøndelag
Health Study (HUNT). We hypothesized that patients
with schizophrenia had reduced VO2peak compared to
normative healthy individuals. The secondary aim was
to evaluate relationships between VO2peak, risk factors
for cardiovascular disease, and quality of life.
Methods
Subjects
We included 33 patients, 11 women and 22 men, with
ICD-10 schizophrenia, schizotypal or delusional disor-
ders (F20 to F29) in the study. Patients were in- and
out-patients at a University hospital and had agreed to
take part in exercise interventions studies. All patients
were under antipsychotic medical treatment. 24 patients
were smokers. Exclusion criteria were known coronary
artery disease, known chronic obstructive pulmonary
disease, and not being able to perform physical treadmill
testing and exercise. Patients were examined by a physi-
cian at inclusion to the study and the exclusion criter-
ions were confirmed by medical records.
Assessments
An individualized protocol was applied to measure
VO2peak and peak heart rate (HRpeak), using the Cortex
Metamax II portable metabolic test system (Cortex Bio-
physik GmbH, Leipzig, Germany) and the Polar S610i
heart rate monitor (Polar Electro, Finland), respectively.
The protocol has previously been described in patients
with schizophrenia as well as in healthy individuals [14,16].
The patients were carefully familiarized with the test
procedures and the treadmill when entering the labora-
tory. Warm-up was ten minute walking or running on
the treadmill at an intensity corresponding to 60-70%
HRpeak. The test started from warm-up speed (with
minimum 5% inclination) after which the speed or the
inclination was increased every minute (0.5-1 km·h-1
and 1-2%, respectively) to a level that brought the
patient to exhaustion. The highest oxygen uptake and
heart rate (HR) recorded during the last minute of the
test were determined as VO2peak and HRpeak, respec-
tively. VO2peak where also presented as ml·kg
-0.75·min-1
to normalise for the differences in bodyweight between
the patients [17].
We compared the patients VO2peak with age and sex
specific strata from the Nord-Trøndelag Health Study
(the HUNT Study) [10]. The HUNT study is an epide-
miological study of the general population in the neigh-
bouring county to the university hospital. The HUNT
Fitness study tested VO2peak in 4 631 healthy individuals
(20 to 90 years) using mixing chamber gas-analyzer
ergospirometry (Cortex MetaMax II, Cortex, Leipzig,
Germany) and an individualised protocol that has close
resemblance to the protocol used in the present study.
14.1% of the participants reported to be inactive, defined
as no activity or exercising less than once per week. For
each patient with schizophrenia, we estimated a norma-
tive VO2peak, namely the mean value defined in the
HUNT Fitness study strata for the corresponding sex
and age. We titled the VO2peak estimated from sex and
age strata independent of physical activity level, as
HUNT general. The VO2peak from age and sex strata for
healthy inactive men and women were titled HUNT
inactive. The percent of HUNT general and HUNT
inactive VO2peak was calculated as: (achieved VO2peak ÷
age predicted VO2peak) · 100.
In the HUNT Fitness study men and women below
44.2 ml·kg-1·min-1 and 35.1 ml·kg-1·min-1, respectively,
were associated with higher cardiovascular risk factor
profile [10]. The same VO2peak values were used as
threshold values when evaluating conventional CVD risk
factors.
Morning fasting blood levels were taken. Serum glu-
cose was analysed using Reflotron Plus system (Roche
Diagnostics, Mannheim, Germany). HDL (high-density-
lipoprotein) cholesterol, total cholesterol and triglyceride
concentrations in serum were measured using a Modu-
lar P chemistry analyzer (Roche Diagnostics, Mannheim,
Germany). LDL cholesterol was calculated using the
Friedewald equation [18]. BP (blood pressure) was mea-
sured using a Maxi-Stabil 3 (Welch Allyn, Jungingen,
Germany). Patients were sitting and had rested for at
least 5 minutes. Risk factors were classified as follows:
hypertension, diastolic pressure ≥ 90 mmHg and/or
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systolic pressure ≥ 140 mmHg; elevated blood glucose, >
6.0 mmol·L-1; elevated total cholesterol, > 6.1 mmol·L-1
in patients < 30 years old, > 6.9 mmol·L-1 in patients
30-49 years old and > 7.8 mmol·L-1 in patients ≥ 50
years old; elevated LDL-cholesterol, 4.3 > mmol·L-1 in
patients < 30 years old, 4.7 > mmol·L-1 in patients 30-49
years old and > 5.3 mmol·L-1 in patients ≥ 50 years old;
reduced HDL-cholesterol, < 1.0 mmol·L-1; elevated tri-
glyceride, > 2.6 mmol·L-1; obesity, BMI ≥ 30.0 kg·m-1
[19,20].
The short form (SF-36) was used to assess the physical
health and mental health aspects of health related qual-
ity of life [21]. SF-36 consists of eight sub scores and
can also be divided into a physical component score
(PCS) and mental component score (MCS). 0 reflect the
poorest health whereas 100 reflect the best health.
The Positive and Negative Syndrome Scale (PANSS)
was used to evaluate the severity of symptoms of schizo-
phrenia [22]. PANSS constitutes three scales measuring
positive (productive symptoms), negative symptoms
(deficit features) and general severity of illness. A total
of 30 items are evaluated on a likert scale ranging from
1 (absent) to 7 (extreme) and added up to a total score
as well as the three sub scores. In this study we used
the positive and negative sub scores (7 items each) as
well as the total score (30 items).
Analyses
We used the independent samples T-test to compare
differences between men and women, between patients
below and above the VO2peak thresholds as well as
between measured VO2peak and HUNT general and
HUNT inactive VO2peak. We used the Pearson chi-
square test to detect whether there was a significant
association between patients above/below the VO2peak
threshold and prevalence of risk factors. We calculated
the odds ratio for having one or more risk factors in
the patients below threshold. The analysis was adjusted
for age and sex. In multiadjusted analysis we also
adjusted for the potential cofounding effect of
smoking.
We used Pearson r to analyse correlations between
VO2peak (ml·kg
-0.75·min-1) and each domain of the SF-36.
The significance level (a) was set at p <0.05 (2-tailed).
Data are described as mean and standard deviation
(SD), unless otherwise noted. SPSS statistical package,
version 18.0 (SPSS Inc.), was applied to analyse results.
The study was approved by the regional committees
for medical and health research ethics, middle Norway
and conducted according to the Helsinki declaration.
Written informed consent was obtained from all the
included patients after the procedures were fully
explained.
Results
Demographics
Age was 33.7 ± 10.4 years and 35.9 ± 11.5 years in men
and women, respectively. The total PANSS, total posi-
tive PANSS and total negative PANSS score was 65 ±
17, 15 ± 6 and 17 ± 8 in men, and 68 ± 23, 16 ± 6 and
18 ± 8 in women, respectively.
Peak oxygen uptake
The VO2peak for the men and women with schizophre-
nia are presented in Table 1. Individual VO2peak values
are plotted against age as well as normative VO2peak
strata from the HUNT Fitness study in Figure 1.
VO2peak in the men with schizophrenia was 84 ± 21% of
age predicted HUNT inactive (p < 0.001) and 74 ± 19%
of HUNT general (p < 0.001). The VO2peak in the
women with schizophrenia was not different from
HUNT inactive (101 ± 28%) and HUNT general (89 ±
25%; n.s.). Age predicted VO2peak was 44.5 ± 2.9 in
HUNT inactive men, 50.3 ± 4.1 ml·kg-1·min-1 in HUNT
general men, 35.2 ± 1.8 in HUNT inactive women and
40.0 ± 3.2 ml·kg-1·min-1 in HUNT general women.
Conventional risk factors
Risk factor assessment was lost in one male patient. Risk
factors were present in 24 of 32 patients and of these
five were above and 19 were below the thresholds.
Among the eight patients without risk factors, six were
above and two were below the thresholds (c2 = 7.6, df =
1, p = 0.006). Based on the odds ratio adjusted for age
and sex patients were 24.2 (95% CI = 1.5-505.6) times
more likely to have one or more risk factors if they were
below the VO2peak threshold. When we also adjusted for
smoking the odds ratio was 28.3 (95% CI = 1.6-505.6).
Among the patients below the VO2peak thresholds 10
patients had hypertension, 11 elevated glucose, 12
reduced HDL-cholesterol, 11 elevated triglyceride and
14 had obesity. Above the thresholds 2 patients had
hypertension, 2 elevated glucose and 1 was obese. There
were 8 smokers above the thresholds and 16 below. Dif-
ferences in mean levels are presented in Table 2.
Quality of life
Results from the SF-36 questionnaire and correlations
between SF-36 variables and VO2peak are presented in
Table 3.
Discussion
Peak oxygen uptake
The present results highlight reduced VO2peak as a
major risk factor for CVD in patients suffering from
schizophrenia. The VO2peak was 37.1 ± 9.2 and 35.6 ±
10.7 ml·kg-1·min-1 in men and women, respectively.
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These values are considerable higher than previous
assumptions [3,13]. Strassnig et al. [3] reported VO2
values of 18.7 ± 6.8 and 13.4 ± 4.6 ml·kg-1·min-1in the
men and women, respectively (mean age of 45.1 ± 10.1
years). These low VO2peak values is to some degree
explained by the high body weight (mean BMI of 36.7 ±
7.5 m·kg2). However, there are some indications of an
underrating of these patients’ VO2peak. First, the patients
only reached a low peak heart rate (142 ± 21 beats·min-
1). Secondly, both Carlsson et al. [13] and Strassnig et
al. [3] applied a cycle ergometer test which is known to
depend more on the patients motivation than a tread-
mill test. Patients with schizophrenia terminate cycle
tests already at submaximal work loads, in contrast to
health subjects [23]. Thirdly, subjects tested on a cycle
ergometer achieve 7-16% lower VO2max compared with
a maximal treadmill test, even when HRpeak is not sig-
nificantly different [24,25].
In contrast to Strassnig et al. [3], the present results
demonstrate that the mean VO2peak in the women was
similar to the men with schizophrenia, even though the
age was similar (36 years in women versus 34 years in
Table 1 Individual characteristics from the peak oxygen uptake test
Patient Age BW VO2peak VO2peak VO2peak VE RER HR
nr years Kg L·min-1 ml·kg-1 ·min-1 ml·kg-0.75 ·min-1 L·min-1 Beats ·min-1
Men
1 21 76.5 3.64 47.6 140.7 126.1 1.07 186
2 21 95.3 3.72 39.1 122.0 107.7 1.09 175
3 24 66.6 3.65 54.9 156.6 138.1 1.19 211
4 25 159.5 4.25 26.6 94.7 134.0 1.19 154
5 25 120.9 3.21 26.5 88.0 115.8 1.09 160
6 26 65.0 3.15 48.5 137.6 100.4 1.22 185
7 26 107.9 4.07 37.7 121.6 126.3 1.23 177
8 27 96.7 3.50 36.1 113.5 102.4 1.11 186
9 27 107.2 3.36 31.3 100.9 94.7 1.04 180
10 28 100.6 2.96 29.4 93.2 69.2 1.00 190
11 29 66.7 2.99 44.8 128.1 121.7 1.13 183
12 31 78.0 3.76 48.2 143.3 118.6 1.41 188
13 31 70.1 3.14 44.8 129.6 106.9 1.10 165
14 37 114.0 3.87 34.0 110.9 109.2 1.10 153
15 40 98.7 2.38 24.1 76.0 65.2 1.00 143
16 41 77.4 3.29 42.0 126.1 110.4 1.21 153
17 41 89.5 3.80 42.5 130.6 105.7 1.22 164
18 41 117.1 3.88 33.1 109.0 118.6 1.06 165
19 45 122.3 3.38 27.7 91.9 125.4 1.08 150
20 47 122.7 2.94 24.0 79.7 89.2 1.00 153
21 50 75.7 3.46 45.7 134.8 90.8 1.08 156
22 58 109.6 3.07 28.1 90.6 91.2 1.07 160
Mean ± SD 33.7 ± 10.4 97.2 ± 24.0 3.43 ± 0.44 37.1 ± 9.2 114.5 ± 22.6 107.6 ± 19.0 1.12 ± 0.10 170 ± 17
Women
1 22 61.7 2.98 48.3 135.4 94.1 1.18 180
2 24 53.3 2.28 42.8 115.6 54.0 0.99 173
3 28 66.4 2.82 42.6 121.2 97.1 1.14 169
4 28 73.5 2.33 31.7 92.8 66.4 1.20 176
5 28 80.3 2.44 30.4 91.0 93.0 1.20 188
6 34 51.6 2.61 50.7 135.6 79.8 1.27 194
7 41 144.5 2.46 17.0 59.0 71.0 1.02 150
8 42 75.5 3.30 43.7 128.8 108.0 1.20 163
9 44 64.9 1.98 30.5 86.6 56.0 1.16 175
10 48 55.5 1.70 30.7 83.6 73.2 1.10 168
11 58 91.8 2.12 23.1 71.5 74.1 1.13 151
Mean ± SD 35.9 ± 11.5 74.5 ± 26.3 2.46 ± 0.46 35.6 ± 10.7 101.9 ± 26.6 78.8 ± 17.4 1.15 ± 0.08 172 ± 14
BW, body weight; VO2peak, peak oxygen uptake; HR, heart rate; VE, total pulmonary ventilation; RER, respiratory exchange ratio; SD, standard deviation
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men). Women normally have about 10 ml·kg-1·min-1
lower VO2peak compared to men at the same age [10].
The mean body weight was 97.2 and 74.5 kg in men
and women, respectively, which partially explain the dif-
ference in VO2peak.
Comparison with healthy individuals
The comparison with normalised VO2peak from the
HUNT Fitness study, confirm our hypothesis that
VO2peak is reduced in men with schizophrenia. The
VO2peak in the women with schizophrenia was almost
identical (101%) to inactive healthy HUNT women.
Even lower VO2peak in men with schizophrenia com-
pared to normative inactive men might suggest that
more than just inactivity contribute the reduced
VO2peak. The VO2peak in the men with schizophrenia is
similar to normative healthy men aged 60-69 years [10].
In other words, the VO2peak in the men with schizo-
phrenia is comparable to healthy men that are about 30
years older. Patients with schizophrenia actually have
15-25 years shorter life expectancy than the general
population [26,27]. It is noteworthy that the VO2peak
presented in the HUNT Fitness study is somewhat
higher than previous described populations with regard
to objectively measured VO2peak [28-31].
Cardiovascular risk
People with reduced VO2peak are consistently being
associated with increased risk of cardiovascular and all-
cause mortality. Kodama et al. [5] found that 3.5 ml·kg-
1·min-1 (1 MET) increases were associated with 13% and
15% reductions in all-cause mortality and CVD/coronary
heart disease, respectively. Aspenes et al. [10] found that
5 ml·kg-1·min-1 lower VO2peak correspond to 56% higher
odds of having a cluster of cardiovascular risk factors.
The comparison of patients with schizophrenia below
and above the VO2peak thresholds suggested by Aspenes
et al. [10] confirm that patients below these thresholds
have higher prevalence of risk factors compared with
patients above the thresholds. Based on the odds ratio
patients were 28.3 times more likely to have one or
more risk factors if they were below the VO2peak thresh-
olds. When comparing mean levels above and below
thresholds, all risk factors, except glucose, was better in
the patients above the thresholds. These findings suggest
a strong connection between the patients VO2peak and
the conventional risk factors for CVD, as confirmed in
other populations [10,32].
Our data are not quite consistent with findings from
US suggesting that especially women with schizophrenia
are at high risk of developing metabolic syndrome [33].
Figure 1 Peak oxygen uptake in patients with schizophrenia and normative healthy men and women. Normative strata are adopted
from the HUNT fitness study [10]. HUNT general strata are age and sex specific strata regardless of physical activity level.
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Table 3 SF-36 items scoresa and Pearson correlation coefficient between SF-36 items and peak oxygen uptakeb
Women (N = 11) Men (N = 19) All (N = 30)
SF-36 items Mean ± SD r Mean ± SD r Mean ± SD r
Physical function (PF) 76.4 ± 28.1 0.68* 82.6 ± 20.2 0.48* 80.3 ± 23.1 0.58***
Role physical (RP) 56.8 ± 35.5 0.61* 67.1 ± 30.1 0.10 63.3 ± 32.0 0.34
Bodily pain (BP) 77.5 ± 24.7 0.06 73.8 ± 26.1 0.11 75.2 ± 25.2 0.26
General health (GH) 58.1 ± 17.6 0.72* 63.6 ± 19.9 0.42 61.6 ± 19.0 0.53**
Vitality (VT) 52.7 ± 22.8 0.71* 51.8 ± 18.6 0.30 52.2 ± 19.9 0.47*
Social function (SF) 51.1 ± 29.8† 0.41 74.3 ± 17.4 0.34 65.8 ± 25.9 0.41*
Role emotional (RE) 42.4 ± 33.7† 0.39 73.7 ± 37.8 0.25 62.2 ± 38.9 0.35
Mental health (MH) 55.3 ± 15.1 0.68* 67.0 ± 16.5 0.08 62.7 ± 16.7 0.34
Physical component (PCS) 49.1 ± 10.3 0.72* 48.2 ± 7.6 0.37 48.6 ± 8.6 0.51**
Mental component (MCS) 36.5 ± 8.4† 0.52 45.6 ± 10.2 0.16 42.2 ± 10.4 0.34
aPatients with schizophrenia
bml·kg-0.75·min-1.
* p < 0.05, **p < 0.005, *** p < 0.001 Pearsons r. † p < 0.05 compared to men, independent T-test.
Table 2 Characteristicsa in patients below and above the threshold peak oxygen uptake (VO2peak)
b
Men
VO2peak (< 44.2) (n = 15) VO2peak (≥ 44.2) (n = 6) Mean difference (95% CI)
Systolic pressure (mm Hg) 139.4 ± 16.8 125.7 ± 11.0 -13.8 (-29.6 to 2.0)
Diastolic pressure (mm Hg) 87.4 ± 7.0 84.3 ± 5.0 -3.0 (-9.7 to 3.6)
Total cholesterol (mmol·L-1) 5.2 ± 0.7 4.5 ± 0.5 -0.7 (-1.3 to -0.0)
HDL cholesterol (mmol·L-1) 1.0 ± 0.3 1.6 ± 0.4 0.5 (0.2 to 0.9)
LDL cholesterol (mmol·L-1) 3.2 ± 0.6 2.5 ± 0.6 -0.7 (-1.3 to -0.1)
Triglyceride (mmol·L-1) 2.1 ± 1.1 0.9 ± 0.2 -1.2 (-1.8 to -0.6)
Glucose (mmol·L-1) 6.4 ± 2.0 5.8 ± 0.6 -0.6 (-2.4 to 1.1)
BMI (kg·m-2) 33.0 ± 5.5 23.6 ± 2.4 -9.5 (-14.5 to -4.5)
Women
VO2peak (<35.1) (n=6) VO2peak (≥35.1) (n=5)
Systolic pressure (mm Hg) 121.6 ± 7.9 103.8 ± 11.9 -17.8 (-32.6 to -3.0)
Diastolic pressure (mm Hg) 80.8 ± 4.4 68.8 ± 8.8 -12 (-22.1 to -1.9)
Total cholesterol (mmol·L-1) 5.0 ± 0.7 4.6 ± 1.0 -0.4 (-1.5 to 0.8)
HDL cholesterol (mmol·L-1) 1.3 ± 0.3 1.8 ± 0.3 0.5 (0.1 to 0.9)
LDL cholesterol (mmol·L-1) 2.9 ± 0.9 2.5 ± 1.1 -0.4 (-1.8 to 1.0)
Triglyceride (mmol·L-1) 1.8 ± 0.7 0.8 ± 0.3 -1.0 (-1.7 to -0.3)
Glucose (mmol·L-1) 6.1 ± 1.5 4.8 ± 0.4 -1.3 (-2.9 to 0.2)
BMI (kg·m-2) 31.2 ± 10.9 23.6 ± 4.5 -7.5 (-19.5 to 4.4)
All
< threshold
(n = 21)
≥ threshold
(n = 11)
Systolic pressure (mm Hg) 134.7 ± 16.8 115.7 ± 15.7 -19.0 (-31.8 to -6.3)
Diastolic pressure (mm Hg) 85.63 ± 6.9 77.3 ± 10.4 -8.4 (-14.9 to -1.9)
Total cholesterol (mmol·L-1) 5.1 ± 0.7 4.6 ± 0.7 -0.6 (-1.1 to -0.0)
HDL cholesterol (mmol·L-1) 1.1 ± 0.3 1.6 ± 0.3 0.5 (0.0 to 0.1)
LDL cholesterol (mmol·L-1) 3.1 ± 0.7 2.5 ± 0.8 -0.6 (-1.2 to -0.1)
Triglyceride (mmol·L-1) 2.0 ± 1.0 0.9 ± 0.3 -1.1 (-1.6 to -0.7)
Glucose (mmol·L-1) 6.3 ± 1.8 5.3 ± 0.7 -1.0 (-2.2 to 0.2)
BMI (kg·m-2) 32.4 ± 7.5 23.6 ± 3.3 -8.8 (-13.7 to -3.9)
amean ± SD.
b44.2 ml·kg-1 ·min-1 in men and 35.1 in women based on the results from Aspenes et al. [10].
HDL, high-density lipoprotein; LDL, low-density lipoprotein; BMI, body mass index.
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This is most likely caused by the women’s fitness level
in the present study, as VO2peak have been described as
a strong independent predictor of metabolic syndrome
[32].
These results emphasize that evaluation of VO2peak
should be incorporated into routine clinical practice for
risk prediction. The prognostic value of VO2peak is
beyond that predicted from other conventional risk fac-
tors [6,34]. Even in individuals with present risk factors,
the higher levels of VO2peak seem to confer a significant
protective effect [4]. Reduced VO2peak is a modifiable
risk factor, and eight weeks aerobic high intensity inter-
val training has provided significant improvements of
VO2peak both in healthy populations [16] and in patients
with schizophrenia [14]. Furthermore, to reduce the risk
of CVD, the interventions are probably more dependent
on improving VO2peak than increasing physical activity
level alone [35,36].
Quality of life
Our findings of lower SF-36 social function, role emo-
tion and mental component score among women than
among men might reflect a sex difference in the general
population. Lower scores for women than for men have
been identified in normative adults [37]. The gender-
specific correlations between items of SF-36 and
VO2peak suggest major gender differences in self-percep-
tion. Only the correlation with between SF-36 physical
functioning and VO2peak was significant in men, whereas
six correlations with the SF-36 were significant in
women. In all subjects together the VO2peak correlated
with the patient’s perception of physical function, gen-
eral health, vitality, social function, and physical compo-
nent score. With some exceptions, these findings are
consistent with correlations between SF-36 variables and
BMI in patients with schizophrenia [38]. In line with
Strassnig et al. [38] we found a significant correlation
with the physical component score but not the mental
component score, suggesting that reduced VO2peak
mainly is perceived as a physical health problem, not
mental. Contrary, both the mental and physical health
components of QOL are found related to estimated
VO2peak in healthy men [12]. An interesting note is,
however, that the patients with lower VO2peak seemed to
experience lower vitality and social functioning. Seden-
tary people are associated with greater risk of low vital-
ity [39]. QOL are found to improve in a dose dependent
manner in sedentary women when increasing physical
activity level [40].
Limitations
There are some limitations of the study. First, the sam-
ple size is low. Secondly, the patients were included in
the study based on request to take part in exercise
intervention studies. However, all eligible patients at the
department were asked to participate in these studies.
Thirdly, severe ill patients with schizophrenia, with poor
insight to their illness, might have difficulties to evaluate
their perception of QOL.
Conclusions
Men with schizophrenia have lower VO2peak than men
in the general population. Patients with a VO2peak below
44.2 ml·kg-1·min-1 (men) and 35.1 ml·kg-1·min-1
(women) have higher odds of having one or more risk
factors for cardiovascular disease. Low VO2peak compro-
mise patients’ perceived physical health. VO2peak should
be regarded as least as important as the conventional
risk factors for CVD and evaluation of VO2peak should
be incorporated in clinical practice. Finally, these finding
represent an urging need for developing effective physi-
cal training interventions for patients with
schizophrenia.
Acknowledgements
Thanks to the patients that volunteered to take part.
Author details
1Norwegian University of Science and Technology, Faculty of Medicine,
Department of Neuroscience, Trondheim, Norway. 2St. Olavs University
Hospital, Division of Psychiatry, Department of Research and Development
(AFFU), Trondheim, Norway. 3St. Olavs University Hospital, Division of
Psychiatry, Department of Østmarka, Trondheim, Norway. 4Norwegian
University of Science and Technology, Faculty of Medicine, Department of
Circulation and Medical Imaging, Trondheim, Norway. 5St.Olavs University
Hospital, Department of Physical Medicine and Rehabilitation, Trondheim,
Norway. 6Hokksund Medical Rehabilitation Centre, Hokksund, Norway.
7Telemark University College, Department of Sports and Outdoor Life
Studies, Bø, Norway.
Authors’ contributions
GM, JH, JH and JH designed the study. JH and GEN recruited patients,
performed VO2peak testing and other data acquisition. GM and JH undertook
the statistical analysis and JH wrote the first draft of the paper. All authors
have contributed to and have approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 4 May 2011 Accepted: 5 December 2011
Published: 5 December 2011
References
1. Brown S, Kim M, Mitchell C, Inskip H: Twenty-five year mortality of a
community cohort with schizophrenia. Br J Psychiatry 2010, 196:116-121.
2. Osby U, Correia N, Brandt L, Ekbom A, Sparen P: Mortality and causes of
death in schizophrenia in Stockholm county, Sweden. SchizophrRes 2000,
45:21-28.
3. Strassnig M, Brar JS, Ganguli R: Low cardiorespiratory fitness and physical
functional capacity in obese patients with schizophrenia. Schizophr Res
2011, 126:103-109.
4. Blair SN, Kampert JB, Kohl HW, Barlow CE, Macera CA, Paffenbarger RS Jr,
Gibbons LW: Influences of cardiorespiratory fitness and other precursors
on cardiovascular disease and all-cause mortality in men and women.
JAMA 1996, 276:205-210.
5. Kodama S, Saito K, Tanaka S, Maki M, Yachi Y, Asumi M, Sugawara A,
Totsuka K, Shimano H, Ohashi Y, Yamada N, Sone H: Cardiorespiratory
fitness as a quantitative predictor of all-cause mortality and
Heggelund et al. BMC Psychiatry 2011, 11:188
http://www.biomedcentral.com/1471-244X/11/188
Page 7 of 8
71
cardiovascular events in healthy men and women: a meta-analysis. JAMA
2009, 301:2024-2035.
6. Myers J, Prakash M, Froelicher V, Do D, Partington S, Atwood JE: Exercise
capacity and mortality among men referred for exercise testing. N Engl J
Med 2002, 346:793-801.
7. McAuley PA, Blair SN: Obesity paradoxes. J Sports Sci 2011, 29:773-782.
8. Lee S, Kuk JL, Katzmarzyk PT, Blair SN, Church TS, Ross R: Cardiorespiratory
fitness attenuates metabolic risk independent of abdominal
subcutaneous and visceral fat in men. Diabetes Care 2005, 28:895-901.
9. Tjonna AE, Lund Nilsen TI, Slordahl SA, Vatten L, Wisloff U: The association
of metabolic clustering and physical activity with cardiovascular
mortality: the HUNT study in Norway. J Epidemiol Community Health 2010,
64:690-695.
10. Aspenes ST, Nilsen TI, Skaug EA, Bertheussen GF, Ellingsen O, Vatten L,
Wisloff U: Peak oxygen uptake and cardiovascular risk factors in 4,631
healthy women and men. Med Sci Sports Exerc 2011, 43:1465-1473.
11. Galper DI, Trivedi MH, Barlow CE, Dunn AL, Kampert JB: Inverse association
between physical inactivity and mental health in men and women. Med
Sci Sports Exerc 2006, 38:173-178.
12. Sloan RA, Sawada SS, Martin CK, Church T, Blair SN: Associations between
cardiorespiratory fitness and health-related quality of life. Health Qual Life
Outcomes 2009, 7:47.
13. Carlsson C, Dencker SJ, Grimby G, Haggendal J: Circulatory studies during
physical exercise in mentally disordered patients. I. Effects of large
doses of chlorpromazine. Acta Med Scand 1968, 184:499-509.
14. Heggelund J, Nilsberg GE, Hoff J, Morken G, Helgerud J: Effects of high
aerobic intensity training in patients with schizophrenia-A controlled
trial. Nord J Psychiatry 2011, 65:269-275.
15. Myers J, Gullestad L, Vagelos R, Do D, Bellin D, Ross H, Fowler MB:
Cardiopulmonary exercise testing and prognosis in severe heart failure:
14 mL/kg/min revisited. Am Heart J 2000, 139:78-84.
16. Helgerud J, Hoydal K, Wang E, Karlsen T, Berg P, Bjerkaas M, Simonsen T,
Helgesen C, Hjorth N, Bach R, Hoff J: Aerobic High-Intensity Intervals
Improve VO2max More Than Moderate Training. Med Sci Sports Exerc
2007, 39:665-671.
17. Rogers DM, Olson BL, Wilmore JH: Scaling for the VO2-to-body size
relationship among children and adults. J Appl Physiol 1995, 79:958-967.
18. Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of
low-density lipoprotein cholesterol in plasma, without use of the
preparative ultracentrifuge. Clin Chem 1972, 18:499-502.
19. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G,
Grassi G, Heagerty AM, Kjeldsen SE, Laurent S, Narkiewicz K, Ruilope L,
Rynkiewicz A, Schmieder RE, Boudier HA, Zanchetti A, Vahanian A, Camm J,
De Caterina R, Dean V, Dickstein K, Filippatos G, Funck-Brentano C,
Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M,
Widimsky P, Zamorano JL, Erdine S, Kiowski W, Agabiti-Rosei E,
Ambrosioni E, Lindholm LH, Viigimaa M, Adamopoulos S, Bertomeu V,
Clement D, Farsang C, Gaita D, Lip G, Mallion JM, Manolis AJ, Nilsson PM,
O’Brien E, Ponikowski P, Redon J, Ruschitzka F, Tamargo J, van Zwieten P,
Waeber B, Williams B: 2007 Guidelines for the Management of Arterial
Hypertension: The Task Force for the Management of Arterial
Hypertension of the European Society of Hypertension (ESH) and of the
European Society of Cardiology (ESC). J Hypertens 2007, 25:1105-1187.
20. Sernyak MJ: Implementation of monitoring and management guidelines
for second-generation antipsychotics. J Clin Psychiatry 2007, 68:14-18.
21. Ware JE, Kosinski M, Gandek B: SF-36 health survey: manual & interpretation
guide Lincoln, RI: QualityMetric Inc; 2000.
22. Kay SR, Fiszbein A, Opler LA: The positive and negative syndrome scale
(PANSS) for schizophrenia. Schizophr Bull 1987, 13:261-276.
23. Deimel H, Lohmann S: Physical capacity of schizophrenic patients.
Rehabilitation (Stuttg) 1983, 22:81-85.
24. Hermansen L, Saltin B: Oxygen uptake during maximal treadmill and
bicycle exercise. J Appl Physiol 1969, 26:31-37.
25. Myers J, Buchanan N, Walsh D, Kraemer M, McAuley P, Hamilton-Wessler M,
Froelicher VF: Comparison of the ramp versus standard exercise
protocols. J Am Coll Cardiol 1991, 17:1334-1342.
26. Hennekens CH, Hennekens AR, Hollar D, Casey DE: Schizophrenia and
increased risks of cardiovascular disease. Am Heart J 2005, 150:1115-1121.
27. Tiihonen J, Lonnqvist J, Wahlbeck K, Klaukka T, Niskanen L, Tanskanen A,
Haukka J: 11-year follow-up of mortality in patients with schizophrenia: a
population-based cohort study (FIN11 study). Lancet 2009, 374:620-627.
28. Jackson AS, Beard EF, Wier LT, Ross RM, Stuteville JE, Blair SN: Changes in
aerobic power of men, ages 25-70 yr. Med Sci Sports Exerc 1995,
27:113-120.
29. Jackson AS, Wier LT, Ayers GW, Beard EF, Stuteville JE, Blair SN: Changes in
aerobic power of women, ages 20-64 yr. Med Sci Sports Exerc 1996,
28:884-891.
30. Talbot LA, Metter EJ, Fleg JL: Leisure-time physical activities and their
relationship to cardiorespiratory fitness in healthy men and women 18-
95 years old. Med Sci Sports Exerc 2000, 32:417-425.
31. Morris CK, Myers J, Froelicher VF, Kawaguchi T, Ueshima K, Hideg A:
Nomogram based on metabolic equivalents and age for assessing
aerobic exercise capacity in men. J Am Coll Cardiol 1993, 22:175-182.
32. Lakka TA, Laaksonen DE, Lakka HM, Mannikko N, Niskanen LK, Rauramaa R,
Salonen JT: Sedentary lifestyle, poor cardiorespiratory fitness, and the
metabolic syndrome. Med Sci Sports Exerc 2003, 35:1279-1286.
33. McEvoy JP, Meyer JM, Goff DC, Nasrallah HA, Davis SM, Sullivan L,
Meltzer HY, Hsiao J, Scott Stroup T, Lieberman JA: Prevalence of the
metabolic syndrome in patients with schizophrenia: baseline results
from the Clinical Antipsychotic Trials of Intervention Effectiveness
(CATIE) schizophrenia trial and comparison with national estimates from
NHANES III. Schizophr Res 2005, 80:19-32.
34. Laukkanen JA, Kurl S, Salonen R, Rauramaa R, Salonen JT: The predictive
value of cardiorespiratory fitness for cardiovascular events in men with
various risk profiles: a prospective population-based cohort study. Eur
Heart J 2004, 25:1428-1437.
35. Blair SN, Cheng Y, Holder JS: Is physical activity or physical fitness more
important in defining health benefits? Med Sci Sports Exerc 2001, 33:
S379-S399.
36. Lee DC, Sui X, Ortega FB, Kim YS, Church TS, Winett RA, Ekelund U,
Katzmarzyk PT, Blair SN: Comparisons of leisure-time physical activity and
cardiorespiratory fitness as predictors of all-cause mortality in men and
women. Br J Sports Med 2011, 45:504-510.
37. Jenkinson C, Coulter A, Wright L: Short form 36 (SF36) health survey
questionnaire: normative data for adults of working age. BMJ 1993,
306:1437-1440.
38. Strassnig M, Brar JS, Ganguli R: Body mass index and quality of life in
community-dwelling patients with schizophrenia. Schizophr Res 2003,
62:73-76.
39. Puetz TW: Physical activity and feelings of energy and fatigue:
epidemiological evidence. Sports Med 2006, 36:767-780.
40. Martin CK, Church TS, Thompson AM, Earnest CP, Blair SN: Exercise dose
and quality of life: a randomized controlled trial. Arch Intern Med 2009,
169:269-278.
Pre-publication history
The pre-publication history for this paper can be accessed here:
http://www.biomedcentral.com/1471-244X/11/188/prepub
doi:10.1186/1471-244X-11-188
Cite this article as: Heggelund et al.: Reduced peak oxygen uptake and
implications for cardiovascular health and quality of life in patients with
schizophrenia. BMC Psychiatry 2011 11:188.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Heggelund et al. BMC Psychiatry 2011, 11:188
http://www.biomedcentral.com/1471-244X/11/188
Page 8 of 8
72
Paper II 
73
74
 Effects of high aerobic intensity training in 
patients with schizophrenia — A controlled 
trial 
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 Background: Patients with schizophrenia have a high risk of cardiovascular disease (CVD). 
High aerobic intensity training (HIT) improve peak oxygen uptake (VO 2peak ), net mechanical 
efﬁ ciency of walking and risk factors for CVD but has not been investigated in patients with 
schizophrenia.  Aims: To investigate effects from HIT on VO 2peak , net mechanical efﬁ ciency 
of walking and risk factors for CVD in patients with schizophrenia.  Methods: 25 inpatients 
(F20 – 29, ICD-10) were allocated to either HIT or playing computer games (CG), 3 days per 
week for 8 weeks. HIT consisted of 4   4-min intervals with 3-min break periods, at 85 – 95% 
and 70% of peak heart rate, respectively.  Results: 12 and seven patients completed HIT and CG, 
respectively. The baseline VO 2peak in both groups combined ( n   19) was 36.8   8.2 ml/kg/min 
and 3.12   0.55 l/min. The HIT group improved VO 2peak by 12% from 3.17   0.59 to 
3.56   0.68 l/min ( P   0.001), more than the CG group ( P   0.014). Net mechanical 
efﬁ ciency of walking improved by 12% in the HIT group from 19.8   3.0% to 22.2   4.5% 
( P   0.005), more than the CG group ( P   0.031). The psychiatric symptoms, expressed as the 
Positive and Negative Syndrome Scale (PANSS) and the Calgary Depression Scale for 
Schizophrenia (CDSS), did not improve in either group.  Conclusions: VO 2peak and net mechani-
cal efﬁ ciency of walking improved signiﬁ cantly by 8 weeks of HIT. HIT should be included in 
rehabilitation in order to improve physical capacity and contribute risk reduction of CVD. 
•  Cardiovascular disease, Exercise, Oxygen consumption, Schizophrenia. 
 J ø rn Heggelund, St. Olav s University Hospital, Division of Psychiatry, Department of 
Research and Development (AFFU), Box 3008 Lade, N-7441 Trondheim, Norway, 
E-mail: Jorn.Heggelund@ntnu.no; Accepted 30 January 2011. 
 Patients suffering from schizophrenia have an illness-related vulnerability to adopt deleterious lifestyles in 
addition to a congestion of cardiovascular and metabolic 
risk factors from antipsychotics and a genetic vulnerabil-
ity for developing cardiovascular disease (CVD) (1). The 
combination of these factors causes impaired physical ﬁ t-
ness, weight gain, obesity, hyperglycemia, type 2 diabe-
tes, hyperlipidemia and ultimately increased risk of CVD 
(2, 3). Although these risk factors are related to the 
physical ﬁ tness level and are improvable with aerobic 
endurance training, there has not been much attention to 
the contribution of poor physical ﬁ tness to the risk of 
CVD in schizophrenia. Reduced physical ﬁ tness also 
compromises the ability to perform lifestyle physical 
activity that is necessary for social rehabilitation and 
integration into the community. Effective aerobic endur-
ance training has the potential to reduce the high risk of 
CVD, and improve functional ability and quality of life 
for patients with schizophrenia, as have been reported in 
other populations with reduced physical ﬁ tness (4). Posi-
tive psychological effects on mental health and well-being 
are also reported in patients with schizophrenia (5). 
 Physical ﬁ tness, measured as peak oxygen uptake 
(VO 2peak ), appears to have more inﬂ uence on risk of 
CVD compared with the physical activity level (6). Rela-
tively small improvement in VO 2peak is associated with a 
fair-sized decrement in risk of all-cause mortality and 
CVD (7). This effect might be induced by an improve-
ment in major risk factors for CVD (8), but physically 
active people have reduced cardiovascular mortality even 
when CVD risk factors are present (9). 
 High aerobic intensity training (HIT) performed as 
4   4-min intervals are found to be an effective training 
method to improve VO 2peak for healthy individuals, 
patients with CVD and metabolic syndrome (10 – 13). 
Studies on patients with schizophrenia have usually 
© 2011 Informa Healthcare DOI: 10.3109/08039488.2011.560278
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 The CG group spent the same amount of time, 36 min 
three times per week, training to improve their ability in 
the computer game, Tetris (THQ Inc. Calabasas Hills, 
CA) using an Xbox Video Game Systems (Microsoft 
Corporation, Redmond, USA). 
 Patients performed the training sessions three times 
per week for 8 weeks. In both groups, training sessions 
were lead and monitored by the same exercise physiolo-
gist. Adherence to at least 19 training sessions (80%) 
during the 8-week period was required to be included in 
the effect analyses. 
 Testing 
 The test started with a 10-min warm-up at approximately 
50 – 60% of VO 2peak . Patients then walked for 6 min on 
the treadmill at an inclination and speed corresponding to 
60 Watt (22, 23). We obtained the measurements of pulmo-
nary gas exchange and heart rate between 5 and 5 ½ min 
walking, using the Cortex Metamax II portable metabolic 
test system (Cortex Biophysik GmbH, Leipzig, Germany) 
and the Polar S610i heart rate monitor, respectively. Net 
mechanical efﬁ ciency of walking is deﬁ ned as the per-
centage of the work input (kilocalories) that is converted 
into work output. The equation for this calculation is 
described elsewhere (22, 23). 
 After testing net mechanical efﬁ ciency of walking the 
patient immediately proceeded with the VO 2peak testing 
protocol. The speed or the inclination was increased 
every minute to a level that brought the patient to 
exhaustion in 3 – 6 min. VO 2peak was accepted when VO 2 
leveled off, despite further increases in speed and when 
respiratory exchange ratio (RER) was above 1.10 (24). 
The highest heart rate recorded during the last minute of 
the test was determined as HR peak . 
 The patients took the pre and post-test fasting blood 
samples in the morning and we calculated low-density 
lipoprotein (LDL)-cholesterol using the Friedewald 
equation (25). 
 Possible changes in positive and negative symptoms were 
assessed using the Positive and Negative Syndrome Scale 
(PANSS) (26). The test was performed by two psychiatric 
nurses, trained in using PANSS, working in the ward and 
had a personal knowledge of the patient. The Calgary 
Depression Scale for Schizophrenia (CDSS) was used to 
assess depressive symptoms (27). The 36-item short form 
(SF-36) was used to assess the physical health and mental 
health aspect of health-related quality of life (HRQOL) 
(28). The SF-36 is a 36-item self-report instrument. 
 Patients were given 10-min to learn the Tetris com-
puter game before testing. Thereafter patients had three 
attempts, and the best of three trials were used in the 
results. We measured performance as total number of 
lines achieved during a game, 
 We accomplished this test for the CG, but not for 
HIT patients. Testing was not done blinded to allocation. 
investigated low-intensity exercise corresponding 
to   70% peak heart rate (HR peak ) (14 – 17). Only a few 
studies have applied direct measurements of oxygen 
uptake (18 – 20), but the exact level of VO 2peak are not 
described. 
 A major concern over the cardiovascular health in 
people with schizophrenia is their ability to engage in 
and participate in physical training. In addition, inherent 
difﬁ culties in recruitment to randomized controlled trials 
and distrust in methodological issues such as randomiza-
tion has been described (15, 21). 
 Aims 
 The objectives of the study were to investigate effects 
from HIT, compared with physical inactivity in the form 
of playing computer games (CG), in patients suffering 
from schizophrenia. The primary outcome was changes in 
VO 2peak and net mechanical efﬁ ciency of walking. The 
secondary outcome was effects on other CVD risk fac-
tors and symptoms of schizophrenia. We hypothesized 
that   80% adherence to 24 training sessions with HIT 
during 8 weeks would improve the primary outcome vari-
ables more than the same amount of time spend on CG. 
 Materials and Methods 
 All inpatients at three wards in a University hospital that 
fulﬁ lled the inclusion criteria were evaluated for eligibil-
ity for the study by the medical doctor. In total 38 
patients were evaluated, one did not meet the inclusion 
criteria, ﬁ ve did not want to participate and seven did not 
participate for other reasons. The ﬁ rst 16 consecutive 
patients were included in the HIT group and the next 
nine consecutive patients were included in the CG group. 
The inclusion criteria were ICD-10 schizophrenia, schizo-
typal and delusional disorders (F20 – F29). Patients were 
on stable antipsychotic medication for 6 weeks prior to 
inclusion. Exclusion criteria were coronary artery disease, 
chronic obstructive pulmonary disease, unstable pharma-
cological treatment during the intervention period, and 
not being able to perform physical treadmill testing and 
exercise. 
 Interventions 
 The HIT group trained 4   4-min interval training on a 
treadmill (Tung Keng Enterprise CO., Ltd, Taiwan) at 
85 – 95% HR peak interspersed with 3 min of active resting 
periods at a work load corresponding to 70% HR peak 
between each interval, previously shown to be highly 
effective (10 – 13). Patients performed the intervals walk-
ing or running with a minimum of 5% inclination. Heart 
rate was assessed continuously during exercise, using a 
Polar S610i heart rate monitor (Polar Electro, Finland). 
The exercise physiologist ensured that the patients per-
formed intervals at the scheduled intensity. 
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 P   0.001), but no change was apparent in the CG 
group. In both groups combined ( n   19), VO 2peak 
was 36.8   8.2 ml/kg/min and 3.12   0.55 l/min at 
baseline. 
 The HIT group improved net mechanical efﬁ ciency of 
walking more than the CG group ( P   0.031, Table 3). 
The net mechanical efﬁ ciency of walking improved from 
pre- to post-test in the HIT group (12%,  P   0.005), but 
no change was apparent in the CG group. In both groups 
combined ( n   19), the net mechanical efﬁ ciency of 
walking was 19.6   2.9% at baseline. 
 A between group change in high-density lipoprotein 
(HDL)-cholesterol was observed (0.18 mmol/l, 
 P   0.007; Table 4). HDL-cholesterol decreased by 
8   8% in the CG group (0.13 mmol/l,  P   0.044). 
 No signiﬁ cant changes were observed between or 
within the two groups in PANSS, CDSS and SF-36 
(Table 5). The CG group improved their performance in 
Tetris, measured as total number of lines achieved, from 
10   11 lines at pre-test to 83   41 lines at post-test 
( P   0.003). 
 Discussion 
 The primary ﬁ nding is that the patients suffering from 
schizophrenia were able to participate in high aerobic 
intensity training and improve their VO 2peak . The HIT 
group improved VO 2peak by 12%. The size of the 
improvement in VO 2peak is in line with effects of 8 weeks 
of training in healthy controls and in patients with CVD 
(10 – 12, 29). It seems fair to conclude that, in line with 
what has been shown for healthy subjects, patients suf-
fering from schizophrenia also beneﬁ t from 8 weeks 
with HIT. 
 The ability to improve VO 2peak is highly related to the 
ability to adhere to the exercise training, which is consid-
ered challenging for patients suffering from schizophrenia. 
The patients included in the present study were inpatients 
that suffered from severe schizophrenia, the majority of 
 The study was approved by the National Committee 
for Medical and Health Research Ethics, Middle Norway. 
The approval number is: 4.2005.1507. ClinicalTrials.gov 
Identiﬁ er: NCT00286299. 
 Statistics 
 We suggested a change in VO 2peak from pre- to post-test 
of 4   3 ml/kg/min for use in the sample size estima-
tion; 18 patients was needed in the study for 80% power 
to detect a between group difference at  P   0.05. Data 
are expressed as mean and standard deviation (s). Differ-
ence in changes from pre- to post-test between groups is 
expressed as mean difference and 95% conﬁ dence inter-
vals (CI). Paired samples  t -test was performed to deter-
mine changes from pre- to post-intervention. Independent 
sample  t -test was performed to test differences at base-
line and changes from pre- to post-test between the two 
groups. The signiﬁ cance level ( α ) was set at  P   0.05 
(two-tailed). 
 Results 
 During the training period, six of the 25 included patients 
did not complete the study and are not included in the 
results: one HIT and one CG patient were discharged 
from the hospital before completion and one HIT patient 
was lost because of ankle pains during running. One CG 
patient disappeared. In addition, two of the HIT patients 
were excluded because they completed less than 80% of 
the training sessions. The patients that discontinued the 
study were not signiﬁ cantly different in any of the mea-
sured baseline variables, compared with the patients that 
completed the study. Patients in the HIT ( n   12) and 
CG ( n   7) groups performed 85   9% and 83   6% 
of the scheduled training sessions, respectively. Charac-
teristics of the patients are presented in Table 1. 
 After 8 weeks of training, the HIT group improved 
VO 2peak more than the CG group (Table 2). VO 2peak 
increased in the HIT group from pre- to post-test (12%, 
 Table 1. Characteristics of the patients. 
High aerobic intensity 
training ( n   12)
Computer game 
training ( n   7)
All
( n   19)
Men/women,  n 9/3 4/3 13/6
Age (years), mean    s 30.5   8.7 38.9   11.4 33.6   10.3
Age at ﬁ rst contact with psychiatric services 
(years), mean    s 
24.8   9.0 25.2   6.3 24.9   7.9
Months of hospitalization, mean    s 35.2   19.6 70.1   62.9 48.0   43.0
ICD-10 diagnosis,  n 
Schizophrenia 11 6 17
Delusional disorder 1 0 1
Schizoaffective disorder 0 1 1
 s , standard deviation. 
 No signiﬁ cant differences between the groups ( P   0.05). 
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13% and 15% decrements in risk of all-cause mortality 
and CVD, respectively. These beneﬁ ts may result from 
an improvement in CVD risk factors, but could also be 
related to other indirect protective mechanisms. The 
present study found an improvement of 4.2 ml/kg/min 
after 8 weeks with HIT, and theoretically a considerable 
reduction in the CVD risk. 
 VO 2peak values are seldom reported in patients suffer-
ing from schizophrenia. Carlsson et al. (18, 19) measured 
oxygen uptake (VO 2 ) in people with schizophrenia in the 
late 1960s. Carlsson et al. (18) presented VO 2 values that 
did not seem to reach VO 2peak in all patients and are 
therefore considerable lower than the current VO 2peak ﬁ nd-
ings. A recent 3-month intervention study found   5% 
and   3% change in VO 2peak in the exercise group and 
non-exercise group, respectively (20). The exact level of 
VO 2peak was not reported. 
 Participation in HIT was associated with improved net 
mechanical efﬁ ciency of walking, compared with the CG. 
The HIT group improved net mechanical efﬁ ciency of 
walking from 19.8   3.1% to 21.9   4.4%, whereas no 
signiﬁ cant change was observed within the CG group. 
This is in line with studies reporting improved work 
the patients had several years of hospitalization and some 
were described as treatment resistant. In spite of the 
severity of their illness, they managed to participate in 
HIT and improve VO 2peak within a short period. This 
effectiveness could have important implications for the 
long-term treatment and prevention of low VO 2peak . 
 In both groups combined, the VO 2peak at inclusion 
was low and can be considered close to normative 
VO 2peak for sedentary people of the same age but well 
below normative values for active healthy people that 
participate in occasional aerobic exercise  	 2 times per 
week (30, 31). Low VO 2peak is associated with higher 
risk of cardiovascular morbidity, obesity, high blood 
pressure, high total- and LDL-cholesterol levels, and 
reduced glycemic control. A resent meta-analysis 
deﬁ ned 28 ml/kg/min (7.9 MET) as a critical level, as 
those with lower than 28 ml/kg/min had substantial 
higher rates of all-cause mortality and CVD events 
compared with those with higher VO 2peak (7). Fortu-
nately, only a modest level of improvement in VO 2peak 
appears to confer a signiﬁ cant protective effect from 
CVD risk factors. Kodama et al. (7) found that every 
3.5 ml/kg/min increase in VO 2peak was associated with 
 Table 2 . Physiological variables measured during peak treadmill exercise. 
High aerobic intensity training 
( n   12)
Computer game training 
( n   7)
Difference pre-post 
between groups
Pre Post Pre Post Mean (95% CI)
VO 2peak (l/min), mean    s 3.17   0.59 3.56   0.68 
∗ ∗ ∗ 3.03   0.51 3.09   0.57 0.33 (0.07 to 0.58) † 
VO 2peak (ml/kg 
/ min), mean    s 36.0   7.4 40.2   6.6 ∗ ∗ ∗ 38.3   9.8 37.9   9.9 4.7 (1.8 to 7.6) † † 
HR (beats/min), mean    s 175   14 172   15 166   14 167   14    4 (  11 to 3)
V E (l/min), mean    s 95.8   21.0 103.0   17.1 91.2   19.9 94.7   22.1 3.7 (  6.5 to 13.9)
RER, mean    s 1.11   0.08 1.12   0.06 1.10   0.10 1.12   0.10 0.00 (  0.06 to 0.05)
 s , standard deviation; VO 2peak , peak oxygen uptake; HR, heart rate; V E , total pulmonary ventilation; RER, respiratory exchange ratio; CI, conﬁ dence 
interval. 
 * * * P   0.001, changes from pre- to post-test. 
 † P   0.05,  † † P   0.01 differences in changes from pre- to post-test between groups. 
 Table 3. Physiological variables measured during 60-Watt submaximal treadmill walking. 
High aerobic intensity training 
( n   12)
Computer game training 
( n   7)
Difference pre-post between 
groups
Pre Post Pre Post Mean (95% CI)
 e net (%), mean    s 19.8   3.0 22.2   4.5 
* * 19.4   3.0 19.4   2.5 2.4 (0.3 to 4.6) † 
VO 2 (l/min), mean    s 1.79   0.32 1.70   0.31 
* * 1.77   0.49 1.77   0.45    0.09 (  0.17 to   0.01) † 
VO 2 (ml/kg/min), mean    s 20.0   2.6 19.3   2.5 
* * 21.5   3.5 21.1   3.2    0.3 (  1.2 to 0.5)
HR (beats/min), mean    s 140   16 133   15 * * 136   17 133   11    4 (  12 to 4)
V E (l/min), mean    s 43.9   10.0 40.9   8.4 45.5   15.7 44.8   12.8    2.4 (  7.4 to 2.7)
RER, mean    s 0.89   0.06 0.91   0.05 0.93   0.04 0.92   0.04 0.03 (  0.03 to 0.08)
 s , standard deviation; VO 2 , oxygen uptake; HR, heart rate; V E , total pulmonary ventilation; RER, respiratory exchange ratio;  e net , net mechanical efﬁ ciency 
of walking; CI, conﬁ dence interval. 
 ∗ ∗ P   0.01, changes from pre- to post-test. 
 † P   0.05 difference in changes from pre- to post-test between groups. 
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 The poor VO 2peak and net mechanical efﬁ ciency of 
walking described in this study might have adverse 
effects that could hamper rehabilitation and reintegration 
into the community, reduce compliance to other treat-
ment regimens, increase stigmatization and discrimina-
tion, have harmful effects on quality of life and physical 
functioning, and increase ﬁ nancial burden (4, 34). Poor 
VO 2peak and net mechanical efﬁ ciency of walking 
involves that lifestyle physical activity, such as walking 
and household chores will demand a higher percentage 
of the patients VO 2peak , making lifestyle physical activity 
less pleasant. Improved endurance performance is shown 
to improve functional status in other populations (4). 
Effective HIT might help the patients to better function 
in general and cope better with their illness. 
 The baseline BMI score in all patients was 28.3 kg/m 2 , 
which is classiﬁ ed as overweight with increased health 
risk. Blood pressure, triglyceride, hs-CRP, total choles-
terol and glucose were within normal values. During 
economy both in students and in patients with post-
infarction heart failure after participation in walking and 
running interventions (10, 12). Walking is an important 
part of daily function and interventions that improve net 
mechanical efﬁ ciency of walking might have great impact 
in the performance on daily tasks and physical activity 
in general. 
 The baseline value for net mechanical efﬁ ciency of 
walking in all patients ( n   19) was 19.6%. This is sim-
ilar to values found in patients with coronary artery dis-
ease (19.2%) and lower than in healthy controls (24.7%) 
(32). It could be assumed that patients with schizophre-
nia walk with mechanical inefﬁ ciency. Psychomotor 
slowing has been recognized as a feature in people with 
schizophrenia and probably contributes to walking 
mechanical inefﬁ ciency (33). However, it also seems con-
nected to inactivity, as we found that net mechanical efﬁ -
ciency of walking could be improved after participation 
in HIT. 
 Table 4. Hematological values and blood pressure. 
High aerobic intensity training 
( n   12)
Computer game training 
( n   7)
Difference pre-post 
between groups
Pre Post Pre Post Mean (95% CI)
Body weight pretest (kg), mean    s 90.1   17.9 89.1   16.6 85.3   29.7 87.1   29.9    2.8 (  .2 to 0.5)
BMI (kg/m2), mean    s 28.8   4.7 28.5   4.5 27.6   8.5 28.2   8.8    0.9 (  2.0 to 0.1)
Systolic pressure (mmHg), mean    s 131   22 135   21 124   22 128   28 0 (  15 to 16)
Diastolic pressure (mmHg), mean    s 82   10 84   12 80   12 79   12 3 (  5 to 12)
Triglyceride (mmol/l), mean    s 1.5   0.9 1.9   1.3 1.8   1.3 1.8   1.2 0.3 (  0.3 to 1.0)
HDL-cholesterol (mmol/l), mean    s 1.21   0.38 1.26   0.30 1.37   0.38 1.24   0.28 ∗ 0.18 (0.06 to 0.31) † † 
LDL-cholesterol (mmol/l), mean    s 3.15   0.86 2.82   0.73 3.10   0.67 2.95   0.84    0.17 (  0.67 to 0.33)
Hs-CRP (mg/l), mean    s 8.09   18.15 2.67   2.11 4.41   5.34 4.26   5.09    5.28 (  18.83 to 8.28)
Total cholesterol (mmol/l), mean    s 5.0   0.8 4.9   1.0 5.3   0.4 5.0   0.7 0.1 (  0.5 to 0.7)
Glucose (mmol/l), mean    s 5.5   0.8 5.6   0.6 6.4   2.8 6.8   3.7    0.3 (  1.1 to 0.5)
 s , standard deviation; BMI, body mass index; HDL, high-density lipoprotein; LDL, low-density lipoprotein; hs-CRP, high-sensitivity serum C-reactive 
protein; CI, conﬁ dence interval. 
 ∗ ∗ P   0.01, changes from pre- to post-test. 
 † † P   0.01 difference in changes from pre- to post-test between groups. 
 Table 5. Psychiatric symptoms and quality of life before and after interventions. 
High aerobic intensity training 
( n   12)
Computer game training 
( n   7)
Difference pre-post 
between groups
Pre Post Pre Post Mean (95% CI)
Total PANSS 74.7   20.9 73.3   24.3 63.4   20.4 61.4   18.9 2.4 (  13.2 to 18.1)
Total positive, mean    s 16.5   6.9 15.2   6.3 14.6   6.1 13.7   7.4 1.4 (  1.7 to 4.5)
Total negative, mean    s 20.3   8.2 23.1   10.0 15.9   10.3 15.3   9.8 3.3 (  2.7 to 9.3)
Total global psychopathology, mean    s 37.8   10.3 35.0   10.7 33.0   7.2 32.4   7.2    2.2 (  10.7 to 6.4)
Total CDSS, mean    s 2.0   2.3 1.9   3.4 4.2   2.4 3.7   1.6 0.4 (  1.6 to 2.4)
SF-36
Physical health, mean    s 52.8   7.7 52.3   7.7 45.7   8.3 47.6   5.6    2.4 (  6.8 to 2.1)
Mental health, mean    s 45.8   10.2 44.9   10.9 44.5   10.5 47.7   2.2    4.1 (  13.9 to 5.8)
 s , standard deviation; PANSS, Positive and Negative Syndrome Scale; CDSS, Calgary Depression Scale for Schizophrenia; SF-36, 36-item short form; 
CI, conﬁ dence interval. No signiﬁ cant differences in changes from pre- to post-test between or within the two groups. 
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 This was an efﬁ cacy trial, and explored if HIT could 
work under ideal circumstances. The patients that adhere 
to less than 80% of the training sessions were excluded. 
The results can be generalized only to patients who 
adhere to the HIT. Additionally, the 8-week intervention 
period is a short period. 
 Conclusion 
 This study indicates that patients with schizophrenia have 
a level of VO 2peak that is associated with increased risk of 
CVD. The patients also seem to have poor net mechani-
cal efﬁ ciency of walking and spend excessive energy dur-
ing walking. HIT can effectively improve VO 2peak and net 
mechanical efﬁ ciency of walking during 8 weeks in 
patients that adhere to training. Treatment for schizophre-
nia should include efﬁ cient aerobic endurance training to 
contribute risk reduction of inactivity-related comorbidity 
and poor physical ability. 
 Declaration of interest :  The authors report no conﬂ icts of 
interest. The authors alone are responsible for the content 
and writing of the paper. 
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Therapeutic effects of maximal strength training
on walking efficiency in patients with
schizophrenia – a pilot study
Jørn Heggelund1,2,3*, Gunnar Morken1,3, Jan Helgerud4,5,6, Geir E Nilsberg3† and Jan Hoff4,7†
Abstract
Background: Patients with schizophrenia frequently have disabling gait deficits. The net mechanical efficiency of
walking (Enet) is an accurate measure often used to evaluate walking performance. Patients with gait deficits have a
reduced Enet with excessive energy expenditure during sub-maximal walking. Maximal strength training (MST)
improves Enet in healthy individuals and is associated with reduced risk of mortality. The aim of this study was to
investigate whether MST improves Enet in patients with schizophrenia.
Methods: Patients (ICD-10 schizophrenia, schizotypal or delusional disorders (F20-F29)) were included in a
non-randomized trial. Patients were assigned to one of two groups: 1) MST consisting of 4x4 repetitions at 85-90%
one repetition maximum (1RM) performed in a leg press apparatus or 2) playing computer games (CG). Both
groups carried out their activity three days per week for eight weeks. 1RM, Enet at 60 watt walking, peak oxygen
uptake (VO2peak), the Positive and Negative Syndrome Scale (PANSS) and the 36-items short form (SF-36) were
measured pre and post intervention.
Results: The baseline Enet was 17.3 ± 1.2% and 19.4 ± 3.0% in the MST (n = 6) and CG groups (n = 7), respectively,
which is categorized as mechanical inefficiency. The MST group improved 1RM by 79 kg (p= 0.006) and Enet by
3.4% (p= 0.046) more than the CG group. The MST group improved 1RM and Enet, by a mean of 83 kg
(p= 0.028) and 3.4% (p= 0.028), respectively. VO2peak at baseline was 34.2 ± 10.2 and 38.3 ± 9.8 mlkg-1min-1 in
the MST and CG groups, respectively, and did not change (p> 0.05). No change was observed in PANSS or
SF-36 (p> 0.05).
Conclusions: MST improves 1RM and Enet in patients with schizophrenia. MST could be used as a therapeutic
intervention for patients with schizophrenia to normalize their reduced Enet.
Keywords: Exercise, Gait disturbances, Walking efficiency, Schizophrenia
Background
Patients with schizophrenia frequently have disabling
gait deficits. Often the patients have decreased walking
speed, reduced stride length and balance deficits [1,2].
Gait deficits occur independently of the side effects of
antipsychotic medication, but conventional antipsychotic
treatment seems to worsen it [1]. Gait deficits influence
the patients’ well-being, quality of life and compliance to
antipsychotic treatment [3,4].
Net mechanical efficiency of walking (Enet) is a common
physiological method used to evaluate walking and the
metabolic consequences of gait deficits. This measure
determines the magnitude of metabolic energy expend-
iture converted into mechanical work during walking. Gait
deficits such as those in Parkinson’s disease increase the
metabolic cost of walking and reduce Enet [5]. Conse-
quently, patients with poor Enet use excessive amounts of
energy to sustain a given sub-maximal workload, which
contributes to an elevated level of physical fatigue.
Findings from our lab indicate that Enet is reduced in
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patients with schizophrenia before entering an endurance
training program [6].
Patients with poor Enet, such as those with coronary ar-
tery disease and peripheral arterial disease, have derived
benefit from lower limb maximal strength training
(MST) [7-9]. MST aims to increase the ability to lift the
highest possible weight in one repetition (1RM) and the
ability to produce high forces at great speed. These
adaptations have shown significant impacts in rehabilita-
tion programs owing to their carry-over effects on
walking performance measured as Enet [8,10,11]. MST
also has a number of beneficial effects, such as increased
basal metabolic rate, improved glucose metabolism and
improved cholesterol levels, that could reduce the high
risk of cardiovascular disease and metabolic syndrome in
patients with schizophrenia [12,13]. Strength training is
scarcely investigated in patients with schizophrenia and
no studies have investigated the effects of strength
training on Enet in patients with schizophrenia.
The objective in this pilot-study was to evaluate effects
of 8 weeks MST on 1RM, Enet, symptoms of schizophrenia
and quality of life. We chose to compare the MST with in-
activity in the form of playing a computer game (CG) over
the same number of sessions. We hypothesized that MST
would improve 1RM and Enet more than inactivity (CG).
Methods
Study design
A controlled pilot study with pre-post intervention design
was carried out. One group performed MST and one
group spent the same amount of time playing computer
games (CG). A non-randomized trial design was incorpo-
rated in this pilot study in order to prevent distrust of
patients due to randomization and to avoid excluding the
most severely ill patients [14]. The sample size estimate
was based on the results of mechanical efficiency from a
similar study showing a 3.4% mean difference in change
between groups with a 95% CI (−0.01 to 6.8). The change
was significant (p< 0.05) using a Mann–Whitney U test
and 6 patients in each group [10]. The CG group also
serves as a control group in another study [6]. All included
patients were considered suitable for participation in both
interventions. We first included patients to the CG group
and then to the MST group. All patients performed pre
and post tests and a supervised intervention three times
per week in 8 weeks. The outcome assessment was not
blinded. To avoid experimenter bias the planned test
protocol was exactly adhered to in both groups.
Patients
Patients were in- and outpatients at the University
Hospital psychiatric department. All patients lived under
supervised conditions. To be included, patients had to
have ICD-10 schizophrenia, schizotypal or delusional
disorders (F20-F29). Patients were excluded if they had
coronary heart disease, chronic obstructive pulmonary
disease, any major changes in pharmacological treatment
during the intervention period, were unable to perform
testing, or adhered to less than 19 training sessions
(80%). Included patients did not perform strength
training or play computer games outside of the study.
The patients’ traditional therapy was unchanged during
the intervention period. All patients took neuroleptics
(Table 1). To clarify inclusion/exclusion criteria and
somatic health a medical doctor performed a health
examination at the beginning of the study. Diagnoses
were confirmed by medical records. Sixteen patients
were included, the first nine were assigned to CG and
the next seven patients were assigned to MST. There
were 5 in-patients included in the study, all of them in
the CG group. Three patients did not complete the
training period: in the CG group one patient was dis-
charged from the hospital before completion and one
Table 1 Characteristics of the included patients a
Maximal
strength
training
(N = 6)
Computer
game
training
(N= 7)
Between
groupsb
p
Male/Female, N 1/5 4/3 0.266c
Age, year 37.5 ± 9.6 38.9 ± 11.4 1.000
Age at first contact with
psychiatric services, year
23.5 ± 7.7 25.2 ± 6.3 0.836
Months of hospitalization 107.5 ± 58.6 70.0 ± 62.9 0.366
Height, cm 162 ± 10 175 ± 10 0.051
Body weight pre-intervention, kg 81.2 ± 32.2 85.3 ± 29.7 1.000
Body weight post-intervention, kg 82.5 ± 30.8 87.1 ± 29.9 0.945
Body mass index pre-intervention,
kgm-2
30.7 ± 11.2 27.6 ± 8.5 0.628
ICD-10 diagnosis, N
Paranoid schizophrenia 2 4 0.592c
Disorganized schizophrenia 1
Undifferentiated schizophrenia 2 2
Unspecified schizophrenia 1
Schizoaffective disorder 1
Use of neuroleptics, N
Clozapine 4 6 0.559c
Clozapine combined with
neuroleptics
3 4
Clozapine combined with
risperidone
1
Risperidone 1
Zuclopenthixol 1
Haloperidol 1
aData is presented as mean ± standard deviation.
bMan-Whitney U Test.
cFisher’s exact test.
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patient disappeared; in the MST group, one patient was
excluded because the patient completed less than 80% of
the training sessions. No acute psychotic episodes were
registered during the intervention. The study was
approved by the National Committee for Medical and
Health Research Ethics (REK Midt) and was conducted
according to the Helsinki declaration. Written informed
consent was obtained from all the included patients after
the procedures were fully explained. Characteristics of
the patients are presented in Table 1.
Interventions
All MST sessions started with a five minute warm-up on
the treadmill at a workload corresponding to 70% of
peak heart rate (HRpeak; the highest heart rate measured
during the last minute of the peak oxygen uptake
(VO2peak) test). MST was then performed at a 54˚ in-
cline leg press machine (Technogym, Italy). The weight
was lowered in a controlled manner in the eccentric
phase until the patient reached 90 degrees in the knee
joint. Then the patients had a short stop (~0.5 second)
before the weight was moved as rapidly as possible to
complete extension. The training volume was four sets
of four repetitions with a load corresponding to 85-90%
1RM. An exercise physiologist supervised the training
sessions and ensured that the training load was
increased with 2.5-5 kg each time patients managed to
perform four sets with the determined load. Rest periods
were three minutes between each set.
The CG group spent 36 minutes three times per week
training to improve their ability in the computer game
Tetris (THQ Inc. Calabasas Hills, CA), using an Xbox
Video Game Systems (Microsoft Corporation, Redmond,
USA). All sessions were monitored and patients were
encouraged to improve performance.
Interventions were performed in the hospital’s physical
training facilities, with easy access for patients and staff.
MST and CG was performed in separate rooms. Mem-
bers of the staff were dedicated to implement the inter-
ventions as an integrated part of the treatment program.
Outcome measurements
Physical testing started with a ten minute warm-up at
the treadmill at approximately 50-60% of VO2peak.
Patients then performed a six minute sub maximal walk
on the DKCity treadmill (Tung Keng Enterprise CO.,
LTD. Taiwan) at a load corresponding to 60 watt (60
Newton meters per second, 60 N  m  sec-1) and
without holding onto the handrails. The speed and
inclination at 60 watt was calculated from the bodymass
(mb) in kilo and elevation on the treadmill using Equa-
tion (1). The speed range used in the calculation was
three to six kilometers per hour (kmh-1) and the eleva-
tion was adjusted accordingly. Sin θ is the sinus to the
angle of elevation on the treadmill.
km  h1 ¼ 60N m  sec
1
mb  9:81Nð Þ  sinθ  3:6km  h
1 ð1Þ
The measurements of pulmonary gas exchange were
obtained between 5 and 5.5 minutes walking, using the
Cortex Metamax II portable metabolic test system
(Cortex Biophysik GmbH, Leipzig, Germany). Heart rate
was assessed concurrently using a Polar S610i heart rate
monitor (Polar Electro, Finland). Enet was determined as
the percentage of the work input (kilocalories) that is
converted into work output, as presented in Equation
(2). _W is the steady power produced during walking,
expressed as the Watt production converted into
kilocalories per minute (Watt  0.01433 Kcalmin-1). The
net metabolic rate (Ėnet) is kilocalories per minute
estimated from the net oxygen consumption and the
caloric value of the corresponding respiratory quotient
(RQ). The net oxygen consumption is calculated by
deducting the estimated resting oxygen consumption
(3.5 mLkg-1min-1) and the horizontal component of
walking (0.1 mLkg-1min-1) [15] from the total oxy-
gen consumption measured during walking.
Enet ¼
_W
_Enet
 100 ð2Þ
Immediately after testing Enet, the patients proceeded
with the VO2peak testing protocol. The speed or the in-
clination was increased every minute until the patient
was no longer able to continue, preferentially within
3–6 min. VO2peak was accepted when VO2 leveled off
despite further increases in speed and when respiratory
exchange ratio (RER) was above 1.10 [16]. The highest
heart rate recorded during the last minute of the test
was determined as HRpeak.
1RM was measured on the leg press machine using
Olympic weights (Eleiko, Sweden). The lift was per-
formed from complete extension to 90 degrees angle in
the knee joint and back to complete extension. The load
was increased successively until the patient was not able
to lift the weight. Test procedures were carefully
explained to the patients.
Symptoms of schizophrenia were assessed with the Posi-
tive and Negative Syndrome Scale (PANSS) [17]. The 36-
item short form (SF-36) self-report instrument was used
to assess the physical health and mental health aspect of
health related quality of life [18]. SF-36 scales are found to
be reliable for patients with schizophrenia [19].
Statistical methods
Data are expressed as mean and standard deviations (SD)
unless otherwise noted. A related samples Wilcoxon test
was used to determine changes from pre to post
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intervention. The Independent Sample Mann–Whitney U
test was used to evaluate the changes and differences be-
tween groups. Categorical variables were tested using
Fisher’s exact test. The significance level was set at p <0.05
(2-tailed). Statistical analyses were performed using the
software program SPSS, version 17.0 (Statistical Package
for Social Science, Chicago, IL).
Results
Patients in the MST (n = 6) and CG (n = 7) groups per-
formed a mean of 85 ± 9% and 83 ± 6% of the scheduled
training sessions, respectively. One patient in the CG
group refused to execute maximal strength testing in the
leg press machine. Apart from this missing test, the
patients performed all of the planned tests.
The two groups did not differ pre-intervention with
regard to 1RM (p= 0.357), Enet (p= 0.063), VO2peak
(p= 0.253), total PANSS (p= 0.517) and SF-36 scores
(physical health score: p= 0.749, mental health score:
p= 0.200). During eight weeks of training, the MST
group improved mean 1RM by 79 kg more than the CG
group (p= 0.006). The MST group improved 1RM with
83 kg (p= 0.028), from mean 218 ± 45 kg to 301 ± 65 kg
while the CG group did not change from pre-
214 ± 100 kg to post-intervention 218 ± 97 (p = 0.465).
Enet improved by 3.4% more in the MST group than in
the CG group (p= 0.046; Table 2). The improvement in
Enet within the MST group was 3.4% (p= 0.028; Table 2).
No change was observed in the CG group (p > 0.999).
Changes in 1RM and Enet from pre- to post-intervention
are presented as percent changes in Figure 1. The VO2
cost of walking at 60 watt was also reduced for the MST
group after the intervention (p= 0.028), but not for the
CG (p= 0.0176; Table 2). The VO2 reduction in the MST
group was not significantly larger than in the CG
(p= 0.063), but was supported by a grater reduction in
pulmonary ventilation (p= 0.032) and the respiratory ex-
change ratio (p= 0.031) in the MST group. No changes
were observed from pre to post-intervention in VO2peak
in either group or between the groups (p > 0.05). Pre-
and post-intervention VO2peak was 34.2 ± 10.2 and
32.3 ± 8.5 mlkg-1min-1 in the MST and 38.3 ± 9.8 and
37.9 ± 9.9 mlkg-1min-1 in the CG group.
No significant changes were observed from pre- to
post-intervention in the two groups in total PANSS
(MST: p= 0.115, CG: p= 0.753), SF-36 physical health
score (MST: p= 0.173, CG: p= 0.116) or mental health
score (MST: p= 0.463, CG: p= 0.345). There were no dif-
ferences in changes between groups (total PANSS:
p= 0.086, physical health score: p= 0.688, mental health
score: p= 0.262). The pre-intervention mean total PANSS
score was 58 ± 12 and 63 ± 20 in the MST and CG groups
respectively. The mean post-intervention PANSS scores
was 68 ± 8 and 61 ± 19, in MST and CG groups
respectively. The SF-36 mean physical health scores at
pre- and post- intervention, were 45 ± 10 and 51 ± 11 in
the MST group and 46 ± 8 and 48 ± 6 in the CG group,
respectively. The mean mental health scores at pre- and
post-intervention, were 36 ± 5 and 35 ± 8 in the MST
group and 45 ± 11 and 48 ± 2 in the CG group,
respectively.
Discussion
The findings indicate that patients with schizophrenia
could safely participate in maximal strength training
with a beneficial improvement in maximal strength and
walking performance due to improved Enet. These
improvements occurred without affecting symptoms of
schizophrenia.
The MST group improved their 1RM in incline leg
press by 38%. This level of improvement is comparable
with findings from studies investigating MST in patients
with heart disease, chronic obstructive pulmonary
disease, healthy subjects and distance runners. Improve-
ments ranging from 27 to 44% have been reported after
8 weeks [8,10,11,20]. In line with the findings of Auchus
Table 2 Physiological variables measured during 60 Watt constant load sub-maximal treadmill walking a
Maximal strength
training (n = 6)
Computer game
training (n= 7)
Difference pre-post
between groups
Pre Post Pre Post Mean (SE)
Net mechanical efficiency of walking (Enet), % 17.3 ± 1.2 20.7 ± 2.9
b 19.4 ± 3.0 19.4 ± 2.5 3.4 (1.6) c
Oxygen uptake
Lmin-1 1.71 ± 0.38 1.60 ± 0.37 b 1.77 ± 0.49 1.77 ± 0.45 −0.12 (0.06)
mlkg-1min-1 22.0 ± 3.1 20.0 ± 2.9 b 21.5 ± 3.5 21.1 ± 3.2 −1.5 (0.7)
HR, beatsmin-1 143± 9 137± 12 136 ± 17 133± 11 −4 (5)
VE, Lmin-1 44.9 ± 12.2 39.9 ± 12.2 b 45.5 ± 15.7 44.8 ± 12.8 −4.4 (1.7) c
RER 0.95 ± 0.06 0.90 ± 0.06 b 0.93 ± 0.04 0.92 ± 0.04 −0.04 (0.01) c
aData is presented as mean ± standard deviation. HR: heart rate, VE: total pulmonary ventilation, RER: respiratory exchange ratio, SE: standard error.
bdifferences within groups from pre to post intervention (p< 0.05).
cdifferences in change between groups (p< 0.05).
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et al. [21] this study suggests that patients with
schizophrenia are able to participate in strength
training and improve their 1RM. The improvement
in 1RM occurred without changes in bodyweight.
The MST group improved Enet significantly more than
the CG group. This is in agreement with the strength
training studies that have addressed effects on endurance
performance. Although clinically significant, the 20% im-
provement in Enet is somewhat smaller compared to
32-35% improvement found in other patient groups [8,10].
This might indicate that factors associated with the illness
itself or side effects from antipsychotic medication may
hamper the transfer effect from improved 1RM to
improved Enet. As expected, the VO2peak did not change.
Maximal strength training mainly results in neural system
adaptations with improved maximal strength and ability
to develop speed. MST does not result in cardiovascular
system changes such as increased peak stroke volume and
increased VO2peak [7]. However, increased VO2peak from
endurance training is often followed by improved Enet [6].
In this respect, the improved Enet in this study is
considered being a result of the MST intervention, not
confounded by increased VO2peak. On the contrary, the
mean VO2peak in the MST group worsened in absolute
terms. The most plausible explanation is that patients
could have reduced their endurance physical activities
during the intervention. No outside intervention activity
control were carried out.
The initial Enet of 17.3% (MST) and 19.4% (CG) can be
considered low and within the range of patients that
walk with mechanical inefficiency [8,22]. The Enet values
in the present study are similar to values found in
patients with coronary artery disease (19.2%) and lower
than in healthy controls (24.7%) [22]. Gait deficits in
schizophrenia have been reported, with the poorest gait
patterns found in patients treated with conventional
antipsychotics [1]. Patients with schizophrenia choose to
walk slower (2.7 to 3.1 kmh-1), compared to healthy
controls (3.4 kmh-1) [1]. From a metabolic point of
view, it seems natural that the patients would walk
slower if they had lower VO2peak and poorer Enet.
Walking is usually undertaken at a speed that coincides
with the lowest metabolic cost. Poor Enet might be an
obstacle in performing daily tasks and so might prevent
patients from engaging in activities that require walking.
Additionally, poor Enet as well as other gait deficits might
have implications for the patients’ well-being [3]. Of
interest, the MST improved Enet to a level that is closer
to healthy individuals [8,22].
Our study revealed no changes in the total PANSS
score or SF-36. In absolute terms, there was an increase
of 10 points in the MST group and a decrease of 2
points in the CG group on the total PANSS score. As
there are no reasons to anticipate an adverse effect from
MST, as would be reflected by an increase in PANSS
score, we believe this tendency of a change is due to
natural variations in the course of the illness and is
probably valid for patients with schizophrenia. There is a
small sample size in this study and other mediators or
moderators such as depression, anxiety or fatigue due to
the intervention were not measured. There are few
reports of strength training on symptoms of schizophrenia.
A single-group study found that patients reported im-
provement in a questionnaire that measured perceived
psychological well being, but no improvement in the Zung
Self Rating Depression Scale (SDS), after weight lifting
therapy [21]. A case study described some improvements
in Brief Psychiatric Rating Scale (BPRS) and the Nurses’
Observational Scale for In-Patient Evaluation (NOSIE 30).
The patient showed beneficial behavior changes in his daily
activities. However, there is a need for larger scale and
longitudinal intervention studies to determine whether
strength training has the ability to decrease symptoms of
schizophrenia. Considering the effect of MST on Enet this
seems to be sufficient reason to include MST in the treat-
ment of schizophrenia. Furthermore, patients with
schizophrenia have a high risk of dying from cardio-
vascular disease [23]. The 8-weeks training period
performed in this study may not be sufficient to
affect traditional measures of cardiovascular disease.
Further studies should consider a longer period to in-
vestigate effects on common blood values. Patients
who maintain a certain level of maximal strength
through life may have a better chance of sustaining
good health. A prospective cohort study of 8762 men
aged from 20–80 years, found that maximal strength
was independently and inversely associated with all-
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Figure 1 Percent changes in one repetition maximum (1RM)
and net mechanical efficiency of walking. MST, maximal strength
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(p< 0.05).
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cause mortality [24]. The association persisted even
after adjusting for cardiorespiratory fitness.
There are some limitations in this study. First, the allo-
cation of patients was not randomized. Thus, a selection
bias cannot be ruled out. To reduce the selection bias
we ensured that all patients were eligible for both inter-
ventions. None of the patients were selected because
they fitted one of the groups more than the other.
Patients were not able to choose a particular group, but
their personal preference for the intervention they were
asked to participate in could have influenced their deci-
sion. A possible disadvantage of the non-randomized
design is disclosed in the fact that the MST tend to
be hospitalized longer, younger at first contact with
psychiatric services and include more women. It could
be hypothesized that both severity of illness and gender
influenced baseline characteristics such as the SF-36, Enet
and VO2peak. On the contrary, the effects of the inter-
ventions might not be very different between genders.
However, the objective of this study was to evaluate the
effects of the intervention those might not be different
between genders. Although the outcome assessments
were not blinded, all tests followed strict procedures and
patients seemed to be motivated to perform their best
regardless of the group. The effect of the intervention
can only be generalized to patients that adhere to MST.
The study also had a small sample size. This might be
one reason for the tendency of a worsening of PANSS
symptoms in the MST group. Furthermore, the 8-week
intervention might be too short a period of time for
patients suffering from schizophrenia to adapt to the
intervention.
Conclusions
The current study found that the MST improved the
patients 1RM to the same level as has been observed in
other patient groups and in healthy controls. The MST
did also improve the patients’ ability to normalize the
net mechanical efficiency of walking. MST is a safe and
effective intervention to improve 1RM and net mechanical
efficiency of walking in patients with schizophrenia.
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